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ABSTRACT
EPIGENOMIC AND TRANSCRIPTIONAL REGULATION OF
HEPATIC METABOLISM BY REV-ERB AND HDAC3
Dan Feng
Mitchell A. Lazar

Metabolic activities are regulated by the circadian clock, and disruption of the clock
exacerbates metabolic diseases including obesity and diabetes. Transcriptomic studies in
metabolic organs suggested that the circadian clock drives the circadian expression of
important metabolic genes. Here we show that histone deacetylase 3 (HDAC3) is
recruited to the mouse liver genome in a circadian manner. Histone acetylation is
inversely related to HDAC3 binding, and this rhythm is lost when HDAC3 is absent.
Diurnal recruitment of HDAC3 corresponds to the expression pattern of REV-ERB, an
important component of the circadian clock. REV-ERB colocalizes with HDAC3 near
genes regulating lipid metabolism, and deletion of HDAC3 or Rev-erb in mouse liver
causes hepatic steatosis. Thus, genomic recruitment of HDAC3 by REV-ERB directs a
circadian rhythm of histone acetylation and gene expression required for normal hepatic
lipid homeostasis. In addition, we reported that the REV-ERB paralog, REV-ERBalso
displays circadian binding similar to that of REV-ERB. REV-ERB also recruits
HDAC3 and protects the circadian clock and hepatic lipid homeostasis in the absence of
REV-ERB REV-ERBs are indeed essential components of the circadian clock
Furthermore, we discovered that REV-ERBs competes with ROR for genomic binding
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at Bmal1 and Npas2 genes, and drives a diurnal binding of ROR. We then identified
thousands of competing sites by ROR ChIP-seq, many of which are in close proximity
of clock and metabolic genes. We also discovered many ROR binding sites with no
rhythmic ROR binding or rhythmic ROR binding in-phase with REV-ERBs.
Collectively, these findings indicate that REV-ERBs, HDAC3 and potentially ROR
mediate the epigenomic and transcriptional regulation of liver metabolism by the
circadian clock.
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Chapter 1
General Introduction
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1.1 Circadian Regulation of Metabolism
The approximately 24 hour cycling of light and dark drives the cyclic changes in the
living environments for most organisms on Earth, from cyanobacteria to human beings.
To adapt to changing environments, organisms anticipate the periodic changes and adjust
their activities with the time of the day using an internal 24 hour clock system, known as
the circadian clock. In human beings and other mammals, the clock governs many
important behaviors and physiological processes including sleep/wake, feeding, body
temperature, hormone secretion and metabolism.

Human beings are diurnal creatures. We conduct most of our activities during the day,
including feeding, exercising and working, and rest at night. Circadian clocks in our
bodies provide time cues for activities, and meanwhile synchronize the metabolic
reactions with the anticipated activity cycles. The synchronization of behaviors and
metabolism by the clock ensures the energy supply and maintains the internal
homeostasis. However, this delicate system has been increasingly challenged in modern
society. Modern life is characterized by increase in night activities, for instance, shift
work, overtime work, night eating, sleep disruption and deprivation. Misalignment of
activities with the internal clock and metabolic rhythms could disrupt the clock and
energy homeostasis. Evidence suggests that shift workers have a higher risk of metabolic
diseases, including obesity, diabetes, metabolic syndromes and cardiovascular diseases
(Antunes et al., 2010; Wang et al., 2011). Similar effects were also observed with sleep
deprivation, sleep disruption and night eating (Reviewed in Huang et al., 2011). In
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recognition of these concerns, much recent research focuses on the crosstalk between the
circadian clock and metabolism.

1.1a The Molecular Clock System
The cell-autonomous clock machinery consists of several transcriptional-translational
feedback loops, which allows autonomous oscillation with a period of approximately 24
hours (Figure 1.1). In mammals, the first feedback loop in the basic clock machinery
contains a heterodimer of transcription activators the brain and muscle ARNTL-like
protein 1 (BMAL1) and the circadian locomoter output cycles kaput (CLOCK).
BMAL1/CLOCK activates transcription of Crytochromes (CRYs) and Periods (PERs).
CRY and PER proteins negatively regulates their own expression by binding
BMAL1/CLOCK and inhibiting their transcriptional activity (reviewed in Levi and
Schibler, 2007). Another critical feedback loop drives the cyclic transcription of BMAL1
using nuclear receptor (NR) REV-ERB/REV-ERB. BMAL1 activates Rev-erb
transcription, which then suppresses Bmal1 transcription (Preitner et al., 2002). The clock
machinery is featured by the redundancy of their components: BMAL1/BMAL2,
CLOCK/NPAS2 (neuronal PAS domain containing protein 2), CRY1/CRY2,
PER1/PER2/PER3, REV-ERB/REV-ERB(DeBruyne et al., 2007; van der Horst et al.,
1999; Shi et al., 2010; Zheng et al., 2001) (Figure 1.1). Other factors that are important
for clock function include the Retinoid-related orphan receptor RORs (ROR, ROR,
ROR), which activate transcription of BMAL1 and REV-ERB, and are repressed by
REV-ERB(reviewed in Jetten, 2009). Levels of the clock proteins are also subject to
posttranslational regulation by casein kinases (CKI and CKI), and ubiquitin E3 ligase
3

-TrCP, FBXL3 and ARF-BP1/PAM (Yin et al., 2010; reviewed in Gallego and Virshup,
2007; Levi and Schibler, 2007).

Although the transcriptional-translational clocks are ubiquitous in mammalian cells, nontranscriptional mechanisms are aslo sufficient to sustain circadian oscillation. In picoeukaryotic alga Ostreococcus tauri, oxidation of peroxiredoxin proteins undergoes
circadian cycles independent of its transcriptional circadian clock (O’Neill et al., 2011).
Recently this mechanism was shown to be conserved in higher organisms including
human, at least in human red blood cells (O’Neill and Reddy, 2011). The wide-spread
presence of transcription-independent redox oscillations suggests that crosstalk between
metabolic cycles and circadian clocks has long played a significant role in both
physiology and evolution.

In mammals, the basic clock machinery is present in most organs, assembled in a
hierarchical system in which the central clock can entrain peripheral clocks (Figure 1.2).
The central clock is located in the suprachiasmatic nuclei (SCN) of the anterior
hypothalamus, while peripheral clocks are present in most organs, including metabolic
organs such as liver, adipose, heart, muscle and kidney (reviewed in Dibner et al., 2010;
Welsh et al., 2010). Both the central clock and peripheral clocks can sense and respond to
environmental changes, and keep synchronized with the environment. The environmental
cues that can rest the clock are known as Zeitgebers (“time-giver”). The predominant
Zeitgeber for the central clock is light, which is sensed by retina and signals directly to
SCN. The central clock can then entrain the peripheral clocks through neuronal and

4

hormonal signals, as well as body temperature, aligning all clocks with the external
light/dark cycle (Balsalobre et al., 2000; Brown et al., 2002; reviewed in Dibner et al.,
2010; Welsh et al., 2010). Peripheral clocks in metabolic tissues are also entrained by the
central clock through feeding/fasting cycles (Figure 1.2). Fasting/feeding alters the levels
of key endocrine hormones and the intracellular metabolic state, which can modulate the
function of peripheral clocks. When restricted food availability shifts the fasting/feeding
cycles, peripheral clocks can be reset separately from the central clock, suggesting that
food availability is the predominant Zeitgeber for these clocks (Damiola et al., 2000;
Stokkan et al., 2001).

1.1b Circadian Oscillation of Metabolism
Metabolic activities undergo diurnal changes, as reflected by the oscillating hormone
levels in blood and rhythmic activities of metabolic pathways. Hormones mediate the
crosstalk between the central nervous system and major metabolic organs, and are
essential to metabolic homeostasis. Some of them are secreted in a circadian manner,
including insulin and glucagon from pancreas, adiponectin and leptin from adipose, and
ghrelin from stomach (reviewed in Froy, 2007). Many metabolic pathways display
rhythmic activities, consistent with levels and activities of the rate-limiting enzymes. For
instance, in liver, gluconeogenesis peaks in the daytime with PEPCK activity (Kida et al.,
1980), and cholesterol and bile acid synthesis peaks around midnight, same as HMGCoA reductase (HMGCR) activity (Back et al., 1969; Higgins et al., 1971). Rhythmic
activities were also observed in xenobiotic metabolism, glycogen metabolism and amino
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acid metabolism, and in other metabolic tissues, such as fat (reviewed in Davidson et al.,
2004; Gimble and Floyd, 2009).

Transcriptomic studies in different metabolic organs and SCN revealed that a large
proportion of the whole transcriptomes, from 3% to 20%, undergo circadian oscillation
(Akhtar et al., 2002; Balsalobre et al., 1998; McCarthy et al., 2007; Panda et al., 2002;
Storch et al., 2002; Ueda et al., 2002; Zvonic et al., 2006). The circadian transcriptomes
are tissue-specific and tightly correlated with cellular functions, supporting that circadian
clocks control metabolic activities through transcriptional regulation of key metabolic
genes. In liver, it includes genes involved in glucose, lipid and xenobiotic metabolism; In
skeletal muscle, it mostly contains genes involved in lipid metabolism; In the SCN, it
includes genes involved in protein-neuropeptide synthesis, secretion and degradation and
regulation of mouse locomoter activity (Akhtar et al., 2002; McCarthy et al., 2007; Panda
et al., 2002). while Circadian control of activities can also be mediated through
translational and post-translational regulation (Reddy et al., 2006).

1.1c The Molecular Clock Controls Metabolic Activities
The role of the circadian clock in metabolic regulation is well supported by genetic
evidence that mutation in clock genes disturbs rhythmic expression of key metabolic
genes and causes metabolic disorders. Key metabolic pathways under clock control will
be discussed in this section. In addition, other metabolic or related pathways are also
regulated by the circadian clock, including cardiovascular function and inflammation
(reviewed in Bass and Takahashi, 2010).
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Glucose homeostasis Loss of BMAL1 attenuates the diurnal variation in glucose and
triglyceride levels, impairs gluconeogenesis and shows glucose intolerance, while the
Clock mutant mice (Clock19) develop hyperglycemia and hypoinsulinemia (Lamia et
al., 2008; Rudic et al., 2004; Turek et al., 2005). Both genetic models suggest that
BMAL1/CLOCK plays a critical role in glucose homeostasis. The study was followed by
tissue-specific deletion of Bmal1 in liver and pancreatic  cells, both of which support
the critical role of peripheral clocks in metabolic tissues. Loss of BMAL1 in liver
abolishes rhythmic expression of glucose metabolic genes, e.g. Pepck and Glut2, and
leads to hypoglycemia only in the fasting phase of the day, while loss of BMAL1 in
pancreatic  cells impairs insulin secretion (Lamia et al., 2008; Marcheva et al., 2010).

Other clock components also play a role. CRYs inhibit gluconeogenic gene expression,
probably through regulating CREB activity. Therefore, hepatic depletion of CRY1/2
increases circulating glucose, while CRY1 overexpression reduces fasting blood glucose
and improves whole body insulin sensitivity in db/db mice (Zhang et al., 2010). CRYs
also transrepress glucocorticoid-induced Pepck transcription, and loss of CRYs results in
glucose intolerance (Lamia et al., 2011). Similarly depletion of both REV-ERBs
increases fasting blood glucose (Cho et al., 2012). And ROR is known to activate
G6pase through SRC-2 and BAF60a (Chopra et al., 2008; Tao et al., 2011).

Lipid metabolism Clock mutation and Bmal1 deficiency also impairs lipid metabolism,
as shown by hyperleptinemia, hyperlipidemia and hepatic steatosis (Shimba et al., 2011;
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Turek et al., 2005). The mechanism behind this remains unclear. REV-ERB agonists
inhibit lipid and cholesterol synthesis in liver and fat, and promote fatty acid and glucose
oxidation in muscle, resulting in increased energy expenditure. These agonists
significantly improve dyslipidemia and hyperglycaemia in a diet-induced obesity model
(Solt et al., 2012). In addition, BMAL1 and REV-ERB both regulates adipocyte
differentiation (Laitinen et al., 2005; Shimba et al., 2005; Wang and Lazar, 2008).

Bile acid metabolism REV-ERB is an important regulator of bile acid synthesis.
Genetic ablation of REV-ERB lowers bile acid synthesis and decreases bile acid
accumulation in the liver, correlated with altered phase and total decrease of Cyp7a1
expression (Duez et al., 2008; Le Martelot et al., 2009). REV-ERBmay indirectly
activates Cyp7a1 via E4bp4 and SHP, or via LXR (Duez et al., 2008; Le Martelot et al.,
2009). REV-ERB also regulates SREBP function through its regulator INSIG2 and thus
the SREBP targets involved in cholesterol and lipid metabolism (Le Martelot et al., 2009).
Loss of BMAL1 increases circulating cholesterol, and loss of PER1/2 up-regulates bile
acid synthesis and results in hepatic cholestasis (Ma et al., 2009; Shimba et al., 2011).

1.2 Clock and Epigenome
1.2a Transcriptional Regulation by the Circadian Clock
How does the circadian clock drive rhythmic gene expression in different tissues? In the
core clock machinery, BMAL1/CLOCK, REV-ERBs, PERs, CRYs and RORs are all
transcription regulators. BMAL1/CLOCK displays rhythmic genome binding and can
drive the rhythmic expression of its targets (Rey et al., 2011; Ripperger and Schibler,
8

2006). REV-ERB directly regulates gluconeogenic enzymes G6pase and PEPCK (Yin
et al., 2007). More importantly, the core clock machinery can drive circadian expression
of many transcription factors, thus extending and enhancing its regulatory function.
Among these factors are nuclear receptors (NRs), such as retinoic acid receptors (RARs),
TRs, peroxisome proliferator-activated receptors (PPARs), GR and short heterodimer
partner (SHP) (Yang et al., 2006). Other transcription factors include the three members
of the Prolin Acidic Amino acid Rich (PAR) domain basic leucine zipper proteins
albumin D-site binding protein (DBP), thyrotroph embryonic factor (TEF), and
hepatocyte leukemia factor (HLF), and the related protein E4BP4. All four of these
proteins bind to D-boxes, but while DBP, TEF, and HLF are activators, E4BP4 is a
repressor. Many of these factors are direct targets of the clock. BMAL1 controls PPAR
and DBP, and REV-ERBcontrols SHP and E4bp4 (Canaple et al., 2006; Duez et al.,
2008). The circadian clock also regulates stability and activity of these factors. PER2
binding promotes ER degradation, regulates PPAR DNA binding, and co-activates
PPAR-mediated transcription (Gery et al., 2007; Grimaldi et al., 2010; Schmutz et al.,
2010), while CRY binding represses GR (Lamia et al., 2011). The clock can also regulate
these factors indirectly, for instance, through their ligands such as glucocorticoid for GR
(Reddy et al., 2007). The clock signal can also be mediated by transcription coactivators
PGC-1 and BAF60a, or through post-transcriptional regulation by microRNAs (Gatfield
et al., 2009; Tao et al., 2011; Wu et al., 2009).
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1.2b Clock Regulation of the Epigenome
In addition to the linear genomic DNA sequences, information affecting the expression of
individual genes can be encoded in the chromatin using mechanisms such as DNA
methylation, histone modification and chromatin remodeling. This additional layer of
gene regulation may be referred to as the epigenome. Epigenomic modification provides
plasticity in gene expression and cellular functions in multi-cellular organisms, and
allows reversible changes in response to changes in the their environment, including light,
temperature, food availability and dietary composition which can affect many
physiological processes, including development, aging, and metabolism (reviewed in
Christensen and Marsit, 2011; Portela and Esteller, 2010).

Transcription factors control gene transcription by facilitating recruitment and activation
of the transcription machinery, or by altering epigenome to recreate a more favorable
environment for transcription, or most of the time both (reviewed in Farnham, 2009).
Accumulating evidence, summarized in this section, implicates the core clock genes as
partners of chromatin modifying enzymes (Table 1.1).

Histone acetylation Histone acetylation undergoes cyclic oscillation with the clock, as
evident in mouse liver, not only at the promoters of the clock genes and but also in a
genome-wide scale (Curtis et al., 2004; Etchegaray et al., 2003; Naruse et al., 2004;
Ripperger and Schibler, 2006). Histone acetylation is controlled by a battle between
HATs and HDACs, both of which have been shown to associate with the clock
machinery and participate in clock-regulated rhythmic gene transcription.
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The BMAL1/CLOCK or BMAL1/NPAS2 heterodimer recruits both HATs and HDACs.
BMAL1 binds transcription coactivator p300 and possibly the CREB binding protein
(CBP), while CLOCK and NPAS2 bind p300 and the CBP-associated factor (PCAF)
(Curtis et al., 2004; Etchegaray et al., 2003; Takahata et al., 2000). All three coactivators
have intrinsic HAT activity. In liver and heart, p300 exhibits a circadian association with
CLOCK or NPAS2, correlating with increase in Per1 mRNA and histone H3 acetylation
on the Per1 promoter (Curtis et al., 2004; Etchegaray et al., 2003). BMAL1/CLOCK also
directly interacts with SIRT1, recruits SIRT1 to the Dbp gene in a timely manner, and
drives rhythmic histone acetylation and gene transcription (Asher et al., 2008; Nakahata
et al., 2008) (Figure 1.5). Moreover, CLOCK itself is a HAT, and its HAT activity is
essential for the rhythmic acetylation at the Per1 promoter and the circadian expression of
Per1 and Dbp (Doi et al., 2006).

PER and CRY direct the negative feedback signal to BMAL1/CLOCK probably through
attenuating their affinity for DNA (Figure 1.1) (Ripperger and Schibler, 2006). In
addition, through interaction with BMAL1/CLOCK, CRY1 can recruit Sin3B corepressor
and HDAC1/2 to the Per1 promoter, and repress Per1 transcription through histone
deacetylation (Naruse et al., 2004). Similarly, PER2 recruit Sin3A corepressor and
HDAC1 through the polypyrimidine tract–binding protein–associated splicing factor
(PSF) to the Per1 promoter (Duong et al., 2011).
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REV-ERBs and RORs are members of the NR family, a family known to employ
multiple coactivator and corepressor complexes for chromatin modification. REV-ERB
recruits nuclear receptor corepressor (NCoR) and HDAC3 to deacetylate histones and
repress transcription (Yin and Lazar, 2005). RORs interact with both corepressors and
coactivators (reviewed in Jetten, 2009), and the rhythmic binding of RORs to the Npas2
promoter are positively correlated with DNA accessibility and histone acetylation
(Takeda et al., 2011).

Histone methylation Whereas histone acetylation is usually associated with
transcriptional activation, methylation has a mixed effect on transcription, depending on
the modification sites. CLOCK interacts with and recruits the mixed lineage leukemia 1
(MLL1), a HMT that specifically promotes H3K4me3, an activation mark. MLL1 is
required for circadian H3K4 methylation and H3 acetylation and for circadian gene
expression (Katada and Sassone-Corsi, 2010). PER1 associates with WD repeatcontaining protein 5 (WDR5), and loss of WDR5 abolishes the circadian H3K4 and
H3K9 methylation at the Rev-erb promoter (Brown et al., 2005). Interestingly, MLL1
and WDR5 can be present in the same methyltransferase complex. BMAL1/CLOCK
binds polycomb protein EZH2 and methylates H3K27 at the Per1 and Per2 promoters,
which is essential for CRY-mediated transcriptional repression (Etchegaray et al., 2006).
BMAL1/CLOCK also recruits JumonjiC and ARID domain-containing histone lysine
demethylase 1a (JARID1a) to the Per2 promoter, though it appears that the circadian
functions of JARID1a may be independent of its histone modifying activity (DiTacchio et
al., 2011).
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Chromatin Remodeling Chromatin remodeling often accompanies histone modification
and transcriptional regulation (reviewed in Strahl and Allis, 2000). One study showed
that RORs recruit the

SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin

remodeling complex subunit BAF60a to drive rhythmic Bmal1 and G6pase expression
(Tao et al., 2011). However, this aspect of clock function is understudied at the present
time.

Rhythmic chromatin modification is not limited to the promoter of clock genes that have
been studied, as ChIP-seq revealed that BMAL1 binds thousands of sites throughout the
genome (Dufour et al., 2011; Rey et al., 2011). In addition, the clock can drive rhythmic
epigenomic programming indirectly through clock-regulated transcription factors, such as
NRs, which then recruit HATs and HDACs.

Non-histone targets of clock-associated histone modifiers Histone modifying enzymes
also target transcription factors, cofactors and enzymes. CLOCK acetylates its partner
BMAL1, and facilitates CRY1 binding and CRY1-mediated transcriptional repression
(Hirayama et al., 2007). CLOCK also acetylates GR, attenuates its DNA binding, and
regulates glucocorticoid response (Charmandari et al., 2011; Nader et al., 2009). SIRT1
counteracts CLOCK-mediated BMAL1 acetylation, deacetylates and degrades PER2 thus
derepressing BMAL1/CLOCK (Asher et al., 2008; Nakahata et al., 2008) (Figure 1.5).
Activation or inhibition of transcription activity will also alter the epigenomic state of the
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target genes. Also clock-associated histone modifiers can be recruited by other
transcription factors and function independent of the clock machinery.

1.3 REV-ERB Is an Orphan Nuclear Receptor
1.3a Nuclear Receptor
REV-ERB is a member of the nuclear receptor superfamily. Nuclear receptors are a
large family of transcription factors that regulate differentiation, development and
metabolic homeostasis in animals (reviewed in Bain et al., 2007). Classical nuclear
receptors are ligand activated, and mediate the effects of important hormones, such as
estrogen, glucocorticoid and thyroid hormone.

Structure of nuclear receptors All members of the nuclear receptor superfamily share a
similar structure. From N-terminal to C-terminal, a nuclear receptor can be divided into
four domains: the N-terminal A/B domain, the DNA binding domain (DBD), the hinge
region and the ligand binding domain (LBD) (reviewed in Bain et al., 2007). Both DBD
and LBD are conserved among the family. Crystal structures show that LBD is a globular
domain made up of approximately 12 -helices (reviewed in Li et al., 2003). LBD
contains a hydrophobic ligand binding pocket and a ligand-regulated transcriptional
activation function 2 (AF-2). AF-2 consists of Helix 12 and several other helices, and
provides a hydrophobic groove that interacts with transcription coactivators (Bledsoe et
al., 2002; Shiau et al., 1998). In addition, LBD is required for dimerization of nuclear
receptors. DBD, as indicted by its name, recognizes and binds specific DNA sequences,
known as the response elements. The core response element is usually a hexanucleotide
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sequence, known as the half site. DBD is connected to LBD through the hinge region.
The N-terminal A/B domain contains another transcriptional activation function termed
as AF-1, and has weak conservation in the family. The variable N-terminal confers
specificity to the functions of different nuclear receptors (Figure 1.3).

Classification of nuclear receptors The nuclear receptor superfamily is usually divided
into three different classes, based on their ligands and DNA binding properties (reviewed
in Bain et al., 2007). The first class is steroid receptors, including androgen receptor (AR),
estrogen receptor (ER) and glucocorticoid receptor (GR). In the presence of the ligand,
steroid receptors dissociate from heatshock proteins, translocate to the nucleus from
cytosol, and bind the palindromic half sites as a homodimer. The second class is the
thyroid/retinoid receptor family, including thyroid receptor (TR) and retinoic acid
receptor (RAR). Unlike the first class, the thyroid/retinoid receptor family stays on the
genome, and ligand binding induces conformational changes in Helix 12, allowing the
interaction with coactivators. They also have different dimerization patterns, and many of
them form heterodimer with retinoid X receptor (RXR). Moreover, their response
elements contain direct repeats of the half sites instead of palindromic sequences. The last
class is known as the orphan nuclear receptor, which contains REV-ERB, its
mammalian paralog REV-ERB and the RAR-related orphan receptors (RORs). Most
nuclear receptors in this class have no known cognate ligands, and they were identified
based on sequence homology to known nuclear receptors. Recent studies identified the
ligands of some of these orphan nuclear receptors, such as bile acids for farnesoid X
receptor (FXR) and fatty acids for peroxisome proliferator-activated receptors (PPARs).
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These receptors are thus considered adopted orphan receptors (reviewed in Sonoda et al.,
2008).

Coregulators of nuclear receptors Nuclear receptors regulate transcription through
recruiting coactivator and corepressor complexes. Coactivator complexes usually contain
histone acetyltransferases (HATs), such as p300 and CBP, and chromatin remodeling
enzymes, such as BRG1, which create an epigenomic environment that favors gene
transcription. Coactivators also help recruit RNA polymerase complex, and directly
promote transcription (reviewed in Hermanson et al., 2002). Corepressor complexes
usually contain histone deacetylases (HDACs), such as HDAC3 in the nuclear receptor
corepressor (NCoR) complex and HDAC1/2 in the nucleosome remodeling and
deacetylation (NURD) complex (reviewed in Perissi et al., 2010). In addition, corepressor
complexes also contain chromatin remodelers, histone methyltransferases and
demethylases.

1.3b REV-ERB
REV-ERB was one of the first orphan nuclear receptor to be discovered (Lazar et al.,
1989; Miyajima et al., 1988). Later, a highly related nuclear receptor REV-ERB was
discovered, as well as a non-mammalian homologue E75, which is present in Drosophila
and C. elegans (Bonnelye et al., 1994; Dumas et al., 1994; Retnakaran et al., 1994;
Segraves and Hogness, 1990). Rev-erb is highly expressed in fat, muscle and brain, and
regulates development in these tissues (Chawla and Lazar, 1993; Chomez et al., 2000;
Downes et al., 1995).
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REV-ERB isoforms REV-ERB has multiple isoforms. In human and rat, there are two
different isoforms of Rev-erb mRNA, transcribed from different promoters. The protein
products of these two isoforms differ in their N-terminal domain (Triqueneaux et al.,
2004). The longer isoform, REV-ERB1, is 614 amino acids long. The shorter isoform
REV-ERB2, with N-terminal encoded in a different first exon, is 106 amino acid shorter.
The importance of having two different isoforms remains unclear (Adelmant et al., 1996;
Chopin-Delannoy et al., 2003).

REV-ERB is a transcription repressor REV-ERB recognizes the classical nuclear
receptor half site, a hexanucleotide AGGTCA sequence. Unlike many nuclear receptors,
REV-ERBdoes not dimerize with RXR. It can bind the half site preceded by an ATrich sequence at the 5’ end as a monomer, or a direct repeat of the half sites separated by
two nucleotides, known as the DR2 element as a homodimer (Harding and Lazar, 1993).
Alternatively, two REV-ERB can bind independently at two half sites spaced apart, and
collaboratively mediate transcriptional repression, as demonstrated in the promoter of the
Bmal1 gene (Yin and Lazar, 2005).

REV-ERB lacks Helix 12, which is responsible for coactivator recruitment. In
consistent with its structure, it primarily functions as a transcription repressor by
recruiting the NCoR corepressor complex. REV-ERB interacts with NCoR through the
CoRNR motif located on the N-terminal of NCoR, and it prefers NCoR over other
corepressors, including the closely related SMRT (silencing mediator of retinoic acid and
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thyroid hormone receptor) (Hu et al., 2001; Ishizuka and Lazar, 2003). Importantly,
REV-ERB interacts with NCoR with a stoichiometry of two REV-ERBs to one NCoR,
as determined by steric preference of their binding interface (Zamir et al., 1997).
Therefore, REV-ERB can only recruit NCoR and conduct active repression when two
REV-ERBs bind two half sites as a homodimer. When REV-ERB binds as a monomer,
it may repress transcription passively by competing with transcription activators, such as
nuclear receptor RORs (Figure 1.4).

The transcription repression activity of NCoR derives from its ability to directly interact
with and inhibit the basic transcriptional machinery and its ability to recruit and activate
histone deacetylase (HDAC) (reviewed in Hu and Lazar, 2000). Although NCoR has
been shown to interact with many HDACs, its deacetylase activity mainly depends on
HDAC3, which we will discuss later (Guenther et al., 2000; Ishizuka and Lazar, 2003; Li
et al., 2000; reviewed in Lazar, 2003). Thus HDAC3 is required for transcription
repression by nuclear receptors, such as TR and REV-ERB (Ishizuka and Lazar, 2003).
Remarkably, the enzyme activity of HDAC3 requires NCoR, which interacts with
HDAC3 through its deacetylase activation domain (DAD) (Guenther et al., 2001).

REV-ERB is a member of the core clock machinery REV-ERB was identified as a
major regulator of the cyclic expression of Bmal1, which is an essential component of the
basic clock machinery. Two REV-ERB half sites were found in the promoter of Bmal1,
and REV-ERB binding to the Bmal1 promoter is inversely correlated with Bmal1
expression in a 24h cycle. Genetic ablation of Rev-erb severely blunted the circadian
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expression of Bmal1, and significantly shortens the circadian period. REV-ERB was
also shown to repress other clock genes, Clock, Cry1 and Per2, and was long known to be
self-regulated (Adelmant et al., 1996; Preitner et al., 2002; Ueda et al., 2002). As a major
repressor of Bmal1, REV-ERB is transcriptionally activated by BMAL1/CLOCK,
forming a negative feedback loop that drives the circadian expression of both Rev-erb
and Bmal1 (Triqueneaux et al., 2004).

The role of REV-ERB in the circadian clock has long been considered auxiliary due to
the generally intact circadian rhythm in Rev-erb deficient mice (Preitner et al., 2002).
However, the basic clock machinery is featured by the redundancy of its components:
Bmal1/Bmal2, Clock/Npas2, Per1/Per2/Per3 and Cry1/2. Except for Bmal1, the loss of
any single component can be compensated by the remaining ones, and the circadian
rhythm is largely preserved (Dallmann et al., 2011; van der Horst et al., 1999; Shi et al.,
2010; Zheng et al., 2001). Similar to other clock components, REV-ERB has a twin
brother, REV-ERB, whose role in circadian rhythms remains unclear. It has been
suspected that REV-ERB compensates for the loss of REV-ERB, and the role of both
REV-ERBs in circadian clocks deserve a careful look.

REV-ERB links the circadian clock and metabolism In addition to its role in circadian
clock, REV-ERB also emerged as an important regulator of several metabolic pathways,
including lipid and cholesterol metabolism. REV-ERB represses apolipoprotein ApoA-I
and ApoC-III, and genetic ablation of Rev-erb leads increased plasma triglycerides and
TG-rich very low density lipoprotein (VLDL) particles in mouse (Raspé et al., 2002; Vu19

Dac et al., 1998). REV-ERB may also regulate fatty acid synthesis through the very
long chain fatty acid elongase Elovl3 and peroxisome -oxidation through enoyl-CoA
hydratase/3-hydroxyacyl-CoA dehydrogenase (HD) (Anzulovich et al., 2006; Kassam et
al., 1999). As discussed in Session 1.1c, REV-ERB also regulates bile acid synthesis
and adipocyte differentiation. As a result of these findings, REV-ERB is believed to be
part of the missing link between the circadian clock and the circadian metabolic activities.

Post-translational regulation of REV-ERB REV-ERB can be phosphorylated by
GSK3 at its N-terminal, and phosphorylation protects REV-ERB from ubiquitinmediated degradation by ARF-BP1 and PAM. Lithium is a potent inhibitor of GSK3
activity, and thus promotes REV-ERB degradation and activates Bmal1transcription
(Yin et al., 2006, 2010). Originally categorized as an orphan receptor, REV-ERB was
recently shown to bind heme. Heme can enhance NCoR recruitment and transcription
repression by REV-ERB (Yin et al., 2007). The significance of this regulation will be
discussed later.

1.4 Metabolic Feedback to the Clock
The circadian clock is regulated by metabolic signals such as fasting/feeding and dietary
factors. Fasting and refeeding regulates the clock gene expression in peripheral tissues,
particularly liver (Kawamoto et al., 2006; Tahara et al., 2011). High fat diet (HFD)
lengthens the circadian period and attenuates clock oscillation (Kohsaka et al., 2007).
Clock-associated histone modifiers such as p300 and SIRT1 are also regulated. Fasting
decreases p300 phosphorylation and activates p300, and induces Sirt1 expression, while
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high fat diet (HFD) inhibits p300 phosphorylation, lengthens the circadian period and
attenuates clock oscillation (Liu et al., 2008b; Rodgers et al., 2005). The impact of
metabolism might be mediated through hormones, such as glucagon and insulin (Liu et
al., 2008b; Tahara et al., 2011), as well as metabolites. The circadian clock can sense the
intracellular metabolite levels, adjust its own rhythm and functions and allows a fine and
precise temporal regulation of metabolic pathways within individual cells. We will focus
on the key metabolites such as NAD+, AMP and heme, though other metabolites may
also play a role.

NAD+/NADH NAD+/NADH redox equilibrium indicates the metabolic state of the cell.
NADH and NADPH directly binds CLOCK or NPAS2 and enhances BMAL1/CLOCK
(or NPAS2) DNA binding, while the reduced form NAD+ binds and inhibits (Rutter et al.,
2001). NAD+/NADH ratio also regulate SIRT1, which deacetylates PER2, BMAL1 and
histones (Asher et al., 2008; Nakahata et al., 2008) (Figure 1.5). Intracelluar NAD+ levels
are circadian, and are critical for circadian clock functions (Sahar et al., 2011).

NAD+ levels are determined both by the fasting/feeding cycles and circadian rhythms.
Fasting induces NAD+ levels in liver, as well as SIRT1 protein levels (Rodgers et al.,
2005). Circadian clocks regulates NAD+ mainly through the NAD+ salvage pathway, in
which NAD+ is synthesized from nicotinamide (NAM), the byproduct of sirtuins, through
the

rate-limiting

enzyme

nicotinamide

phosphoribosyltransferase

(NAMPT).

BMAL1/CLOCK drives the circadian expression of NAMPT and contributes to the
rhythmic NAD+ levels. NAD+ activates while NAM represses SIRT1, which interacts
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with BMAL1/CLOCK and inhibits NAMPT transcription. Therefore, NAD+ drives a
negative feedback on its own synthesis through SIRT1 and the circadian clock, and
through NAD+, the intracellular metabolic state can regulate the clock (Figure 1.5)
(Nakahata et al., 2009; Ramsey et al., 2009).

NAD+ is also a substrate of poly(ADP-ribose) polymerase 1 (PARP-1), an NAD+dependent ADP-ribosyltransferase. PARP-1 activity oscillates in a daily manner, and is
regulated by feeding. PARP-1 binds and poly(ADP-ribosyl)ates clock at the onset of the
light phase, regulates BMAL1/CLOCK interaction with PER and CRY and
BMAL1/CLOCK DNA binding, and mediates food entrainment of the liver clock. NAD+
might play a role in regulating PARP-1 activity by feeding, but other mechanisms are
also involved (Asher et al., 2010).

AMP/ADP AMP and ADP bind AMPK, inhibit AMPK dephosphorylation and activate
its kinase activity. Therefore, AMPK functions as a sensor of energy state in the cell,
which is reflected by AMP and ADP levels (Cantó and Auwerx, 2011). Several studies
place AMPK as a circadian clock regulator (Lamia et al., 2009; Um et al., 2007, 2011;
Vieira et al., 2008) with two different mechanisms: AMPK activates CKI and promotes
PER2 degradation(Um et al., 2007); AMPK phosphorylates Cry1 and destabilizes it
(Lamia et al., 2009) (Figure 1.5). AMPK also regulates the NAD+/NADH ratio, through
which it crosstalks with SIRT1 (Cantó et al., 2009).
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Heme As we discussed earlier, heme is a ligand of REV-ERB and REV-ERB, and
enhances corepressor recruitment and transcriptional repression (Pardee et al., 2009;
Phelan et al., 2010; Raghuram et al., 2007; Yin et al., 2007) (Figure 1.5). Through heme,
REV-ERBs can sense the redox state and gas such as O2, NO and CO, as they regulate
REV-ERB structure and corepressor recruitment (Pardee et al., 2009). Also heme binding
can be regulated by the redox state of the REV-ERB protein (Gupta and Ragsdale,
2011). Heme is also a component of NPAS2, whose heterodimeric DNA binding with
Bmal1 is inhibited by CO (Dioum et al., 2002; Gilles-Gonzalez and Gonzalez, 2004).

Like NAD+, heme can also negatively regulate its own synthesis through the circadian
clock. The control is exerted on the expression of the rate-limiting enzyme in heme
biosynthesis, -aminolevulinate synthase (ALAS1), whose expression is circadian. Heme
inhibits BMAL1/NPAS2-activated ALAS1 expression and heme biosynthesis (Kaasik
and Lee, 2004). In parallel, through REV-ERB, heme represses PGC-1 transcription, a
potent inducer of heme biosynthesis (Wu et al., 2009) (Figure 1.5). Both NAD+ and heme
are critical metabolites and indicators/sensors of the metabolic state in the cells. The
negative metabolite feedback loops connect metabolism with the circadian clock, and are
critical for metabolic homeostasis and fine tuning of the clock function.

1.5 Rhythmic Regulation of Metabolism by Food Intake
A key unanswered question is whether the rhythmic feature of metabolism is a passive
response to the fasting/feeding cycles in metabolic tissues or an active anticipatory
mechanism directly governed by the circadian clock. Recent transcriptomic studies in
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mouse liver provide some insight. Liver-specific overexpression of REV-ERBabolishes
oscillation of almost all the rhythmic transcripts found in wildtype mice, suggesting that
they are controlled by the liver clock (Kornmann et al., 2007). Meanwhile, only a small
subset of these transcripts, including the clock genes, maintain their oscillation under
fasting, suggesting most of the rhythmic transcripts are also regulated by fasting/feeding.
Interestingly, in clock deficient mice restricted feeding can resume oscillation of about 60%
of the rhythmic transcripts and even increase their amplitude, along with many other nonrhythmic genes (Vollmers et al., 2009). These observations suggest that under normal
conditions, peripheral clocks and fasting/feeding cycles work together to drive rhythmic
gene expression and metabolic activities.

Fasting/feeding activities are usually aligned with sleep/wake cycles, and are timed by
the central clock. Therefore, normally both the central clock and peripheral clocks
synergize in rhythmic metabolic regulation. In addition to feeding/fasting, the central
clock can also drive metabolic activities through hormones and body temperature (Brown
et al., 2002; Reddy et al., 2007). For instance, blood glucocorticoid levels exhibits
circadian oscillation (Oster et al., 2006). In the absence of the central clock, daily
glucocorticoid injection can restore about 60% of the liver circadian transcriptome,
probably through hepatocyte nuclear factor 4 (HNF4) (Maywood et al., 2007; Reddy
et al., 2007). Therefore, under normal conditions, the central clock synchronize peripheral
clocks, fasting/feeding cycles, hormone secretion and body temperature changes, and all
of these contribute to the rhythmic metabolic activities throughout the body (Figure 1.2).
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On the other hand, fasting/feeding is also subject to food availability in the environment,
and changes in metabolic profiles as induced by fasting/feeding can impact and even
reset the peripheral clocks in metabolic tissues. Thus, in addition to the clock regulating
metabolism, metabolism can regulate the clock.

1.6 Hypothesis and Objectives
In mammals, metabolic processes in peripheral organs display robust circadian rhythms,
coordinated with the daily cycles of light and nutrient availability. Circadian
misalignment causes metabolic dysfunction, and people engaged in night-shift work
suffer from higher incidences of obesity, diabetes, and metabolic syndrome.
Transcriptomics evidence suggests that circadian control of metabolism is achieved
through transcriptional and probably epigenomic regulation of metabolic genes. In this
dissertation, we explore the role of histone deacetylase HDAC3, an epigenomic modifier,
in the circadian regulation of hepatic metabolism. First we hypothesize that HDAC3
displays circadian genomic binding in mouse liver, and drives rhythmic histone
acetylation and thus oscillation of important metabolic genes. HDAC3 is thus critical for
metabolic homeostasis in liver. To address this hypothesis, in Chapter 3, we profile
HDAC3 binding and histone acetylation in mouse liver genome at different times of the
day, and reveal the role of REV-ERB in regulating HDAC3 genomic binding. Next, we
hypothesize that other nuclear receptors, particularly the highly related REV-ERB and
RORs, also play an important role in the circadian regulation of hepatic metabolism. In
Chapter 4, we examine how these nuclear receptors work with REV-ERB and HDAC3
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in regulating circadian rhythms and metabolism. Chapter 5 summarizes the work and
discussed the future directions.
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Figure 1.1 The Core Machinery in Mammals. The core clock machinery consists of
two transcriptional-translational feedback loops. In the first loop, BMAL1/ClOCK
activates transcription of Per and Cry, whose proteins bind and repress BMAL1/CLOCK
activity. A second loop, once considered auxiliary, controls Bmal1 expression;
BMAL1/CLOCK activates Rev-erb and Rev-erb transcription, and REV-ERB proteins
repress Bmal1 transcription. The core clock proteins are also subject to post-translational
regulation by AMPK, CKI/, rCP1/FBXL3 and ARF-BP1/PAM. BMAL1/CLOCK
and REV-ERBs also control the expression of output genes, driving circadian rhythms in
metabolism, feeding, locomotor activity and others.
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Figure 1.2 Assembly of the Circadian Clocks in Mammals. The circadian clocks in
mammals are assembled in a hierarchical manner. The central clock, located in the SCN
in hypothalamus, regulates and synchronizes the peripheral clocks located in many
metabolic organs including liver through neuronal and hormonal signals (Grey arrow).
However, the predominant Zeitgeber for the liver clock is food intake, which regulates
the liver clock and metabolic rhythms through hormonal and nutritional signals. When
restricted food availability shifts the fasting/feeding cycles, peripheral clocks can be reset
separately from the central clock.

28

A/B
AF-1

DBD

H

LBD
AF-2

Figure 1.3 Schematic Structure of Nuclear Receptor. A typical nuclear receptor can be
divided into four domains: the N-terminal A/B domain, the DNA binding domain (DBD),
the hinge region (H) and the ligand binding domain (LBD). The LBD binding domain
contains activation function 2 (AF-2), which mediates coactivator recruitment and
transcriptional activation. The A/B domain contains activation function 1 (AF-1).
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Figure 1.4 REV-ERB-Mediated Transcription Repression.
A. REV-ERB binds as a monomer at a nuclear receptor half site (AGGTCA) preceded
by an A/T-rich sequence, and does not recruit corepressors.
B. REV-ERB binds as a homodimer at the DR2 element (direct repeat of half sites
separated by 2 nucleotides) and recruits the NCoR corepressor complex and HDAC3.
C. REV-ERB binds independently at two half sites spaced apart, but cooperatively
recruits the NCoR corepressor complex and HDAC3.
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Figure 1.5 Metabolite Regulation of the Clock. BMAL1/CLOCK and REV-ERBs drive
rhythmic metabolic outputs, including NAD+ and heme biosynthesis, while intracellular
NAD+ and heme feedback on the clock through their sensors, SIRT1 and REV-ERBs,
respectively. Intracelluar AMP levels regulates the circadian clock through activation of
AMPK and degradation of PER and CRY. The core clock also drives many metabolic
pathways in different tissues, which also contribute to the intracellular metabolite pool
and metabolic state.
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Table 1.1 Clock-associated Chromatin Modifying Activities
Clock
Component
BMAL1
/CLOCK

Associated
Chromatin
Modifier
Clock

p300

Targets

References

H3K9, H3K14
Bmal1(K537),
GR
H3

(Doi et al., 2006;
Nader et al., 2009;
Charmandari et al., 2011)
(Etchegaray et al., 2002;
Takahata et al., 2000)
(Curtis et al., 2004)
(Takahata et al., 2000;
Curtis et al., 2004)
(Asher et al., 2008;
Nakahata et al., 2008)

PCAF
CBP
SIRT1

MLL1

BMAL1
/NPAS2
PER

CRY
REV-ERB

EZH2
JARID1a
p300
PCAF
ACTR
PSF-Sin3AHDAC1
WDR5
Sin3B-HDAC1/2
NCoR-HDAC3

H3K9, H3K14,
Bmal1(K537),
Per2
H3K4
H3K27
H3, H4
H3, H4
H3, H3K9,
H4K5
H3K4
Histone H3, H4
H3, H4, H3K9

(Katada and SassoneCorsi, 2010)
(Etchegaray et al., 2006)
(DiTacchio et al., 2011)
(Curtis et al., 2004)
(Curtis et al., 2004)
(Curtis et al., 2004)
(Duong et al., 2011)
(Brown et al., 2005)
(Naruse et al., 2004)
(Ishizuka and Lazar, 2003;
Yin and Lazar, 2005;
Feng et al, 2011;
Bugge et al, 2012)
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Chapter 2
Material and Methods
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Animals
WT C57Bl/6 mice were purchased from Jackson Labs. The Rev-erbα knockout mice
were obtained from B. Vennström, and backcrossed ≥7 generations with C57/Bl6 mice.
The HDAC3fl/fl mice were produced from C57Bl/6 embryonic stem cells with loxP sites
flanking exon 4 to exon 7, which encode the catalytic domain of HDAC3 (Mullican et al.,
2011). The HDAC3fl/fl mice were then crossed with Alb-Cre mice to generate
HDAC3fl/fl/Alb-Cre mice. The ROR sg/sg mice was purchased from Jackson Labs.

8 to 12 week old WT and mutant male mice were housed under the 12h-light/12h-dark
(LD) cycles (lights on at 7 AM, lights off at 7 PM) for at least 2 weeks, and euthanized at
ZT10 (5 PM) or ZT22 (5 AM). For constant darkness, light remained off after 12h
darkness, and mice were euthanized either 10h later (CT10) or 22h later (CT22). For
restricted feeding, mice were kept in LD cycles for 2 weeks with food available only
between ZT3 and ZT11, and euthanized in constant darkness at CT10 or CT22. All the
animal care and use procedures followed the guidelines of the Institutional Animal Care
and Use Committee of the University of Pennsylvania.

Liver tissues from the chronic jet-lag mice and the Cry DKO mice were a gift from Dr.
Loning Fu at the Baylor College of Medicine.

Synchronized MEFs
MEFs were collected at embryonic day 13.5 from wild-type or Rev-erbα-null embryos,
expanded, and seeded in 24-well plates at a density of 5 × 104 cells per well. The MEFs
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were washed in PBS and incubated for 20 h with 5.7 × 109 particles (GC) of adenovirus
per well in DMEM containing 0.5% bovine serum. Serum shock was performed by
replacing starvation medium with 50% horse serum for 2 h. Following two washes in
PBS, cells were changed back to DMEM containing 0.5% bovine serum, and total RNA
was harvested at the indicated time points.

Antibodies and reagents
HDAC3 antibodies were purchased from Abcam (ab7030, for ChIP-Seq and western blot)
and Santa Cruz (sc-11417, for validation). REV-ERBα antibody was purchased from Cell
Signaling Technology (#2124). REV-ERBβ antibody was raised in a rabbit against amino
acids 243–261 (Covance). Acetylated H3K9 antibody was purchased from Millipore
(#07-352). Two ROR antibodies were purchased from Santa Cruz: C-16 (sc-6062) for
ChIP-seq and H-65 (sc-28612) for validation. p300 antibody was purchased from Santa
Cruz (sc-585).

Constructs and gene transductions
The adeno-associated viruses encoding Cre recombinase (AAV-Cre) and GFP (AAVGFP) were obtained from the Vector Core of the Penn Diabetes and Endocrinology
Research Center. The Cre or GFP gene was inserted into the AAV2/8 vector containing
the liver specific Tbg promoter (Gao et al., 2002). Each 12 week old male HDAC3fl/fl
mouse received 1.5 ×1011 particles of virus through tail-vein injection. The adenoassociated virus encoding mouse ROR4 was constructed using the same AAV2/8 vector
containing Tbg promoter as AAV-GFP. The virus was packaged by the Vector Core of
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the Penn Diabetes Research Center. Each mice received 4 × 1011 particles (GC) of virus
through tail vein injection. The adenoviruses encoding shRNA targeting the βgalactosidase

(TGCACCTGGTAAATCTTAT)

or

the

Rev-erbβ

gene

(GCACTAAGGACCTTAATAATG) were constructed using the BLOCK-iT adenoviral
RNAi expression system from Invitrogen (#K4941-00) and subsequently amplified and
purified by the Vector Core of the Penn Diabetes Research Center. Each mouse received
5.7 × 1011 particles (GC) of virus through tail vein injection.

Chromatin Immunoprecipitation (ChIP)
Mouse liver was harvested immediately after euthanasia. It was quickly minced and
cross-linked in 1% Formaldehyde for 20 min, followed by quenching with 1/20 volume
of 2.5 M glycine solution, and two washes with 1× PBS. Nuclear extracts were prepared
by Dounce homogenization in cell lysis buffer (5mM PIPES, 85mM KCl, 0.5% Igepal
and complete protease inhibitor tablet from Roche, pH8.0). Chromatin fragmentation was
performed by sonication in ChIP SDS lysis buffer (50 mM HEPES, 1% SDS, 10 mM
EDTA, pH7.5), using the Bioruptor (Diagenode) for the HDAC3, Rev-erbα and RNA Pol
II ChIP, or by MNase (Sigma) digestion (6U/ml for 20 minutes) in MNase digestion
buffer (20mM HEPES, 100mM NaCl, 1.5mM CaCl2, 3mM MgCl2 and 1mM PMSF,
pH7.5) for H3K9 acetylation. Alternative: Frozen mouse liver was ground in liquid
nitrogen, and cross-linked; After wash, the cross-linked liver was directly sonicated in
ChIP dilution buffer (50 mM HEPES, 155 mM NaCl, 1.1% Triton X-100, 0.11% Nadeoxycholate, 0.1% SDS, and complete protease inhibitor tablet, pH7.5). Proteins were
immunoprecipitated in ChIP dilution buffer using different antibodies. Cross-linking was
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reversed overnight at 65°C, and DNA isolated using phenol/chloroform/isoamyl alcohol.
Precipitated DNA was analyzed by quantitative PCR.

Quantitative PCR
Quantitative PCR was performed with Power SYBR Green PCR Mastermix and the
PRISM 7500 instrument (Applied Biosystems), and analysis was performed by the
standard curve method. Primer sequences used for ChIP-PCR analysis can be found in
Supplemental Table 2.

ChIP-seq
For each factor, ChIP was performed independently on liver samples from 4 or 5
different mice, and the precipitated DNA or input DNA samples were pooled. 10ng of the
pooled DNA were then amplified according to ChIP Sequencing Sample Preparation
Guide provided by Illumina, using enzymes from New England Biolabs and PCR
Purification Kit and MinElute Kit from Qiagen. Deep sequencing was performed by the
Functional Genomics Core (J.Schug and K. Kaestner) of the Penn Diabetes
Endocrinology Research Center using the Illumina Genome Analyzer IIx, and sequences
were obtained using the Solexa Analysis Pipeline.

ChIP-seq peak calling and data normalization
The sequences identified were mapped to the mouse genome (NCBI36/UCSC mm8)
using BOWTIE software (Langmead et al., 2009). Only the sequences uniquely mapped
with no more than 2 mismatches in the first 28 bp were kept and used as valid reads. Peak
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calling for HDAC3, NCoR and REV-ERB was carried out by MACS (version 1.4.0b,
allowing multiple reads aligning at the same location; options --mfold 10,30 --pvalue 1e5), on each ChIP-seq file against the matching input file (Zhang et al., 2008a). H3K9Ac
ChIP-seq data was processed by NPS (Zhang et al., 2008b), applying the wavelet
denoising to define H3K9ac enriched well-positioned nucleosomes. The signal files
generated from MACS or NPS (aligned reads encompassing each locus), were
normalized to the sequencing depth (per million total reads). Except for the H3K9Ac
data, PeakSplitter (Salmon-Divon et al., 2010) was further applied to split the nearby
peaks and find the peak summits by using the normalized signal files, limiting the height
of peak summit to a minimum of 1. The peak summits were used as the binding site
centers, and the normalized signal files were used as the binding strength for further
analysis.

Binding sites annotation and profiling
CEAS (Cis-regulatory Element Annotation System) (Shin et al., 2009) was applied to
calculate the enrichment of the binding sites in the promoter, exon, intron, UTR and other
genomic regions against the mappable mouse genome using the binomial model. CEAS
was also used to generate the aggregation plot of the normalized binding signals at ± 1 kb
surrounding site centers at 10 bp resolution. The binding signals of different factors and
conditions surrounding each site centers are clustered by k-means clustering with the k
parameter for the number of clusters set to 7. The kmeans function in R is used and the
centers for each cluster are sorted before the heatmap is drawn. The heatmap color scale
indicates the binding signals per million total reads for individual factors. The heatmap of
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Pol II ChIP-seq signals was aligned at transcription start sites considering the orientation
of genes.

Motif analysis
To find the enriched DNA motifs at HDAC3 binding site centers, a de novo motif scan by
MDscan algorithm (Liu et al., 2002) and a search against JASPAR motif collection were
performed at 600 bps windows around site centers. The motifs were further adjusted
according to the distance from motif locations to the HDAC3 binding site centers. Details
of the algorithm are as follows:

Known DNA motifs that are enriched relative to the center of ChIP-seq sites were
identified using the following statistic. All sites were trimmed or expanded to 600 bp
centered at the middle point of the identified ChIP-enriched regions. All subsequences
within the designated window from the site centers were scored by a JASPAR motif or a
de novo motif from MDscan algorithm to identify hits with a relative entropy cutoff t. Let
xi, a value between 0 and 1, denote the relative location of motif hit i on the ChIP regions,
where 0 is the center of the ChIP region and 1 the edge. Out of N total motif hits, we
define a z-score,



N
i1

(x i  0.5) / N /12 to assess the positional bias of a motif towards

the center of the regions. Different integer cutoffs t ≥ 3 were tested for each motif, and
 resulting from the highest z was selected. This statistic is based on the
the cutoff

assumptions that non-significant DNA motifs will be uniformly distributed across the
ChIP regions and the null distribution of



N
i1

x i can be estimated as the N-fold

convolution of uniform density functions.
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Gene expression microarray
Liver samples were taken from the HDAC3fl/fl mice 1 week after injection of AAV-Cre or
AAV-GFP virus (4 mice per group). Total RNA was extracted from each liver sample
using the RNeasy Mini Kit (Qiagen). Each RNA sample was processed with the Ambion
WT Expression Kit and the GeneChip WT Terminal Labeling and Controls Kit
(Affymetrix), and hybridized to the Mouse Gene 1.0 ST Array (Affymetrix). The array
was then read by GCS3000 laser scanner (Affymetrix), and microarray data analysis was
carried out using Partek® Genomics Suite software (Copyright, Partek Inc.). Data from 8
samples were subjected to background subtraction, quantile normalization, log2
transformation and probeset summarization using RMA (Robust Multichip Average)
algorithm. Only the probe sets that interrogate genes were retained and those meant for
QC and normalization purposes were excluded from further analysis. Within Partek, a 1way ANOVA using genotype as the factor was run on the data to obtain p-values for
differential expression of genes between the knock-out and WT mice. The p-values were
adjusted for step-up p-value or False Discovery Rate (FDR) for each gene. Fold-change
was multiple testing using the Benjamini-Hochberg step-up method. The gene expression
microarray and subsequent data analysis were performed by Penn Microarray Core. All
mouse RefSeq genes were ranked based on their expression index in the HDAC3fl/fl mice
injected with AAV-GFP (considered as WT). The top 10%, middle 10% and bottom 10%
were selected for HDAC3 association study. Genes up-regulated or down-regulated in the
AAV-Cre injected mouse were selected with a maximum p-value 10-3 or a minimum
absolute fold-change of 1.2. The circadian gene list was obtained from CIRCA website
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(Hughes et al., 2009), with a maximum COSPOT q-value of 0.001. Based on this list, all
known genes were divided into circadian genes and non-circadian genes for HDAC3
association study. The Rev-Erb knockout expression data were downloaded from
ArrayExpress (E-TABM-726) (Le Martelot et al., 2009).

Association study of HDAC3 and REV-ERB sites
A gene is bound by HDAC3 or REV-ERB at ZT10, if a predicted binding site is present
within 10kb from its TSS. Percentages of genes bound by HDAC3 were compared among
the following gene categories: 1. top 10% expressed, middle 10% and bottom 10%
expressed genes at ZT10; 2. the up-regulated and down-regulated genes upon loss of
HDAC3; 3. the circadian and non-circadian genes. The hypergeometric-based test was
used to calculate the p-value of whether or not HDAC3 or REV-ERB binding is
significantly enriched in the gene categories comparing to all known mouse genes. The
distribution function for hypergeometric distribution (phyper from the statistics language
R) is used as: pvalue = phyper(q,m,n,k,lower.tail=T/F), where m is the number of all the
genes bound by HDAC3 at the promoter region and n is the number of genes without
HDAC3 binding, out of k genes in certain category (e.g. circadian genes) q is the number
of genes bound by HDAC3. The lower.tail is set to F while we calculate the pvalue for
enrichment or T for depletion. Gene ontology analysis is performed on PANTHER
website (Thomas et al., 2003).

Analysis of ROR ChIP-seq
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Sequencing reads were mapped to the mouse genome (UCSC mm8) using Bowtie
(version 0.12.8). Mapped read must have unique alignment with no more than two
mismatches in first 27bp. Only uniquely mapped reads were used for peak calling which
was performed using FindPeaks algorithm (0.1% FDR) in the HOMER software suite
(version 3.15., Heinz et al., 2010). Read density plot was produced using HOMER. Read
density heatmap was generated by seqMiner (Ye et al., 2011). ChIP-seq tracks were
visualized by Integrated genome viewer (IGV). Motif mining was performed by HOMER
using 200bp window size.

Oil Red O staining
5μm frozen sections were prepared from snap-frozen liver tissues, and fixed in 10%
buffered formalin for 3 minutes. The sections were then stained in 0.5% Oil Red O in
propylene glycerol overnight for lipid and then in hematoxylin for nucleus for 5 seconds.
The procedures were performed by the Morphology Core in the Penn Center for
Molecular Studies in Digestive and Liver Diseases.

Hepatic triglyceride assay
Liver samples were homogenized in the TissueLyser (Qiagen) with steel beads in tissue
lysis buffer (140mM NaCl, 50mM Tris and 1% Triton-X, pH8.0). Triglyceride
concentration in the lysates was then quantified using LiquiColor Triglyceride Procedure
No. 2100 (Stanbio).

De novo lipogenesis
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Mice were injected with deuterated water (20 ul/g body weight) intraperitoneally and
euthanized 3 h post injection. 2H-labeled palmitate was extracted from liver and its
trimethylsilyl derivative was analyzed using gas chromatography-electron impact
ionization mass spectrometry (GC/MS), and normalized to body water enrichment. The
percent contribution of newly made palmitate was determined using the equation: %
newly made palmitate =[total 2H-labeled palmitate/ (2H-labeled body water ×n)] ×100
where n is the number of exchangeable hydrogens, assumed to equal 22. The absolute
amount of newly synthesized palmitate was determined by multiplying the % newly
made palmitate by the concentration of palmitate (Leavens et al., 2009).
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Table 2.1 List of Primers for Gene Expression
Gene

Forward Primer

Reverse Primer

Arbp

TCATCCAGCAGGTGTTTGACA

GGCACCGAGGCAACAGTT

Bmal1

TAGGATGTGACCGAGGGAAG

TCAAACAAGCTCTGGCCAAT

Npas2

CAGCTTGAACCCAAAGGAAT

CCATTACAGGAGGGGCTAGG

ROR

TGTTTGATTGATCGGACCAG

CTTGGACATCCGACCAAACT
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Table 2.2 List of Primers for ChIP-PCR
Gene

Forward Primer

Reverse Primer

Arbp

GAGGTGGCTTTGAACCAGAG

TCTTTGTCTCTGTCTCGGAAAA

Ins

GGACCCACAAGTGGAACAAC

GTGCAGCACTGATCCACAAT

Bmal1

AGCGGATTGGTCGGAAAGT

ACCTCCGTCCCTGACCTACT

Npas2

TTGCAGAAGCTTGGGAAAAG

TTTCCTGTGGGAGGAGACAG

HDAC3 binding sites
1

AGACCTGGCAGTTGCATTTT

TGGACGGACAGTCGAGTAGA

2

CCTTGGCTGCATACTGAGGT

AGAGCCAGGTGAGATCCTGA

3

GGGAGGAAATGGAGAAGAGG

CAAATGGAGTTCCCAGCAAT

4

TGGCCAGATGCTCAGAGTTC

ACAGAAGCATGAGGCCAACT

5

AACTCTCAGCCTCCAGAGCA

GGACAGGTCACCAGGGTATG

6

GAGTGTGCGCCAGAGATACA

CCTTGGCTGAGGGACTGTAA

ROR binding sites
1

TCCTTATGCCACTTCCAAAA

ATGCTAAACCACCCACTGGT

2

GCTGACGTCTACAATTGGGTTA

CAATTGACTCCTTTGGCTCTG

3

TGATGACAGCTTTCCCAACA

GCCCATGTGACATTCCCTAT

4

AGCCAAAACAGGTTGCCTAA

GGTGAAGGTCAGCTGGAAAA

5

CCAAGGTCATGTTCATGCTG

TGGGTCAGTCACTTTGGTCA

6

GTCTGTAATGGGGCCATCG

GGCTGCCAAAACCACTATGT
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Chapter 3
A Circadian Rhythm Orchestrated by HDAC3
Controls Hepatic Lipid Metabolism

Published in Science, 2011, 331(6022):1315-9.

The text, figures, and legends in this chapter were the work of Dan Feng with the
following exceptions. Zheng Sun conducted gene expression microarray, hepatic
triglyeride assay, Oil Red O staining and de novo lipogenesis assay in the HDAC3fl/fl
mice, and provided the picture of livers from the HDAC3fl/fl; Alb-Cre mice. Anne Bugge
assisted in the hepatic triglyceride assay and Oil Red O staining in the Rev-erb
knockout mice. Tao Liu conducted the bioinformatics analysis. David Zhuo provided
technical assistance.
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3.1 Abstract
Disruption of the circadian clock exacerbates metabolic diseases including obesity and
diabetes. Here we show that histone deacetylase 3 (HDAC3) recruitment to the genome
displays a circadian rhythm in mouse liver. Histone acetylation is inversely related to
HDAC3 binding, and this rhythm is lost when HDAC3 is absent. Although amounts of
HDAC3 levels are constant, its genomic recruitment in liver corresponds to the
expression pattern of the circadian nuclear receptor REV-ERB. REV-ERB colocalizes
with HDAC3 near genes regulating lipid metabolism, and deletion of HDAC3 or REVERB in mouse liver causes hepatic steatosis. Thus, genomic recruitment of HDAC3 by
REV-ERB directs a circadian rhythm of histone acetylation and gene expression
required for normal hepatic lipid homeostasis.

3.2 Introduction
3.2a Circadian Metabolism and Histone Acetylation
In mammals, metabolic processes in peripheral organs display robust circadian rhythms,
coordinated with the daily cycles of light and nutrient availability (reviewed Green et al.,
2008; Ramsey and Bass, 2011). Maintaining the circadian rhythms in metabolism is
critical for metabolic homeostasis. Circadian misalignment causes metabolic dysfunction,
and people engaged in night-shift work suffer from higher incidences of obesity, diabetes,
and metabolic syndrome (De Bacquer et al., 2009; Pietroiusti et al., 2010; Scheer et al.,
2009). The molecular basis of this is unknown, but genetic disruption of circadian clock
components in mice leads to altered glucose and lipid metabolism (Lamia et al., 2008;
Marcheva et al., 2010; Rudic et al., 2004; Turek et al., 2005).
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Gene expression profiles in multiple metabolic organs have revealed a circadian control
of the transcriptome, which might be mediated by regulation of histone acetylation that
alters the structure of the epigenome (Akhtar et al., 2002; Balsalobre et al., 1998;
McCarthy et al., 2007; Panda et al., 2002; Storch et al., 2002; Ueda et al., 2002; Zvonic et
al., 2006). Histone acetylation undergoes cyclic oscillation with the clock, as evident in
mouse liver, not only at the promoters of the clock genes and but also in a genome-wide
scale (Curtis et al., 2004; Etchegaray et al., 2003; Naruse et al., 2004; Ripperger and
Schibler, 2006). Histone acetylation is complex, involving multiple histone
acetyltransferase (HATs) and histone deacetylases (HDACs) (Strahl and Allis, 2000). .

3.2b Histone Acetylation and Histone Deacetylase
In eukaryotes, genomic DNA is packaged with histone proteins. There are four core
histone proteins: H2A, H2B, H3 and H4. Histones form an octamer with two copies of
each core histone, and each octamer is wrapped by genomic DNA of approximately
146bp, forming the basic unit of chromatin, known as the nucleosome. All histone
proteins have a 15-30 amino acid unstructured N-terminal, known as the histone tails.
The tails contains multiple lysine residues, which are subject to covalent modification,
such as acetylation, methylation and ubiquitination. Here we only discuss histone
acetylation.
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Numerous evidences demonstrate that histone hyperacetylation is highly correlated with
transcription activation, and suggest that histone acetylation can promote transcription.
However, the cause-and-effect relationship has not been confirmed (Kimura et al., 2005).
Multiple lysines in the histone octamer can be acetylated in vivo, including histone H3
lysine 4 (H3K4), H3K9, H3K14, H3K18, H3K23, H3K27, H4K5, H4K8, H4K12 and
H4K16. It was originally believed that histone acetylation activates transcription through
neutralizing positive charges and reducing the electrostatic interaction between histones
and the negatively charged DNA. Such a model was strongly challenged by the findings
that acetylation on different lysines has specific effects and that HATs and HDACs have
residue specificity (reviewed in Kimura et al., 2005; Strahl and Allis, 2000).

Histone deacetylases (HDACs) can be divided into four different classes: Class I
(HDAC1/2/3/8), Class II (HDAC4/5/6/7/9/10), Class III (sirtulins), and Class IV
(HDAC11) (reviewed in Witt et al., 2009). Class I HDACs are usually members of the
multi-protein corepressor complexes, and are critical for transcriptional regulation and
histone modification. For instance, HDAC1 and HDAC2 are in the NuRD complex,
while HDAC3 is in the NCoR and SMRT complexes. Here we only focus on HDAC3,
which is known to function in the regulation of circadian rhythm and glucose metabolism
(Alenghat et al., 2008).

HDAC3 is ubiquitously expressed, and plays an crucial role in development and
metabolic homeostasis. Germline deletion of HDAC3 causes embryonic lethality before
day 9.5. In mouse embryonic fibroblasts (MEFs), loss of HDAC3 also leads to a delay in
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cell cycle progression, cell cycle dependent DNA damage and apoptosis (Bhaskara et al.,
2008). Liver-specific knockout of HDAC3 causes hepatic steatosis (Knutson et al., 2008).

3.3 Results
3.3a Circadian Binding of HDAC3 at ZT10 and ZT22 in Liver
We hypothesized that HDAC3 displays different genomic binding and transcriptional
activity at different times of the day. To test this hypothesis, we kept wildtype C57Bl/6
mice under 12h-light/12h-dark cycles for at least two weeks in an isolated chamber
without disturbance (Figure 3.1). We profiled HDAC3 bindings at two time points:
5pm/ZT10 and 5am/ZT22 using chromatin immunoprecipitation followed by massively
parallel DNA sequencing (ChIP-seq), and discovered diurnal recruitment of HDAC3 to
the mouse liver genome. At ZT10, in the light period when mice are inactive, HDAC3
bound over 14,000 sites in adult mouse liver (the HDAC3 ZT10 cistrome). At ZT22, in
the dark period when mice are active and feeding, only 120 specific peaks remained
(Figure 3.2A). The binding signals at the binding sites decreased significantly from
ZT10 to ZT22 (Figure 3.2B, C), which was also validated with ChIP-PCR using a
different antibody (Figure 3.3A). HDAC3 binding was absent when HDAC3 was deleted
in liver, suggesting that the antibody used for ChIP-seq is highly specific to HDAC3
(Figure 3.3B). Further analysis of the HDAC3 ZT10 cistrome revealed that a majority of
these binding sites were distant from transcription start sites (TSSs) or present in introns
(Figure 3.4).
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HDAC3 recruitment oscillates in a 24-hour cycle (Figure 3.5). Such a rhythm was
retained in constant darkness (Figure 3.6A), suggesting that it was controlled by the
circadian clock. The liver clock is entrained by food intake (Damiola et al., 2000) and,
indeed the pattern of HDAC3 enrichment was reversed when food was provided only
during the light period (Figure 3.6B), further supporting the conclusion that the rhythm of
HDAC3 genomic recruitment was controlled by the liver clock.

3.3b Histone Acetylation Is Inversely Correlated with HDAC3 Binding
Despite its known role in histone deacetylation and transcriptional repression, HDAC3
recruitment has been reported to be associated with high histone acetylation, RNA
polymerase II (Pol II) recruitment, and gene expression in human primary T cells (Wang
et al., 2009). In mouse liver, HDAC3 recruitment at ZT10 was also enriched around
active genes (Figure 3.7A), and many of these display circadian expression patterns
(Hughes et al., 2009)( Figure 3.7B). Thus HDAC3 may have an important role in
transient regulation of these active genes by the circadian clock.

Consistent with this hypothesis, we observed decreases in acetylation of histone H3
lysine 9 (H3K9) at ZT10 compared with that at ZT22, the inverse of HDAC3 recruitment
to these sites (Figure 3.8A,B). We then deleted HDAC3 in mouse liver by tail vein
injection of adeno-associated virus expressing cre-recombinase (AAV-Cre) into adult
C57Bl/6 mice homozygous for a floxed HDAC3 allele (HDACfl/fl)(Figure 3.3B). Loss of
HDAC3 led to H3K9 acetylation at ZT10 comparable that of wild type (WT) mice at
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ZT22 (Figure 3.8). Our results suggest that circadian binding of HDAC3 drives rhythmic
histone acetylation in the mouse liver genome.

In consistent with its role in histone deacetylation and transcription repression, HDAC3
binding is associated with transcription repression. The majority of genes whose
transcripts were increased 1 week after HDAC3 deletion in liver displayed HDAC3
binding within 10 kb of their TSSs in WT mice at ZT10 (Figure 3.7C). Thus, genomewide diurnal recruitment of HDAC3 directs a rhythm of epigenomic modification and
gene expression.

3.3c REV-ERB Mediates HDAC3 Recruitment
Although HDAC3 recruitment to the genome was diurnal, the abundance of HDAC3 was
constant throughout the light/dark cycle (Figure 3.10A). In addition, HDAC3 does not
bind genome directly, and is usually present in the NCoR/SMRT corepressor complex,
which mediates transcription repression by nuclear receptors (Guenther et al., 2000;
Ishizuka and Lazar, 2003; reviewed in Hu and Lazar, 2000). Moreover, HDAC3 enzyme
activity requires interaction with nuclear receptor (NR) corepressors (Guenther et al.,
2001). Therefore, we hypothesized that HDAC3 is recruited by nuclear receptors in a
circadian manner. In consistent with our hypothesis, De novo motif analysis of the
HDAC3 binding sites revealed the classical motif recognized by a number of NRs
(Figure 3.9).
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The NR REV-ERB is a transcriptional repressor that is expressed in a circadian manner,
and the abundance of REV-ERB protein oscillated in phase with HDAC3 recruitment
(Preitner et al., 2002) (Figure 3.10A). REV-ERB is also known to recruit the NCoR
corepressor complex and HDAC3 to repress transcription of Bmal1 (Yin and Lazar,
2005). To test the hypothesis that REV-ERB recruits HDAC3 in a circadian manner, we
used ChIP-seq to identify the REV-ERB binding sites. At ZT10, the REV-ERB
binding sites overlapped with the majority of HDAC3 binding sites (Figure 3.10B). The
binding signals decreased significantly in the Rev-erb knockout liver, suggesting that
the signals are specific to REV-ERBFigure 3.10C). Similar to HDAC3, a majority of
the REV-ERB binding sites were distant from TSSs or in the introns (Figure 3.11A,B).
In consistent with the hypothesis that REV-ERB recruits HDAC3 to repress its target
genes, most of the genes upregulated in liver depleted of REV-ERB (Kornmann et al.,
2007) were bound by HDAC3 as well as REV-ERB at ZT10 (Figure 3.11C).

Furthermore, REV-ERB bound the majority of HDAC3 ZT10 sites at ZT10 but not
ZT22 (Figure 3.12B). The extent of overlapping between HDAC3 binding and REVERB binding was surprising given that other NRs can interact with corepressors and
HDAC3 (Goodson et al., 2005). However, HDAC3 recruitment was indeed diminished at
many sites in Rev-erb knockout mice (Figure 3.13A), consistent with a critical role for
REV-ERB in HDAC3 recruitment. The residual HDAC3 binding at other sites suggests
that other factors also contribute to its recruitment. A likely candidate is REV-ERB,
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whose DNA binding domain is 95% homologous to the REV-ERB(Renaud et al., 2000;
Retnakaran et al., 1994).

REV-ERB recruits HDAC3 via the nuclear receptor corepressor (NCoR) (Yin and
Lazar, 2005; Zamir et al., 1997). The NCoR ZT10 cistrome largely overlapped with the
REV-ERB cistrome and the HDAC3 cistrome (Figure 3.12A). NCoR was recruited to
HDAC3 sites with a similar diurnal rhythm (Figure 3.12B). Like HDAC3, NCoR binding
at many REV-ERB binding sites was also attenuated in Rev-erb knockout mice
(Figure 3.13B). In conclusion, our findings support the hypothesis that HDAC3 is
recruited by REV-ERB through NCoR in a circadian manner.

3.4c HDAC3 Regulates Hepatic Lipid Biosynthesis
In order to understand the biological role of the circadian genomic recruitment of
HDAC3 in mouse liver, we performed gene ontology study on genes bound by REVERB and HDAC3, and upregulated in livers depleted of HDAC3. We defined genes
bound by REV-ERB as genes that have at least one REV-ERB binding site within
10kb from the TSSs. This set of genes are most likely the direct targets of HDAC3, and
were enriched in genes involved in lipid metabolic processes (Figure 3.14). Therefore, we
hypothesized that circadian binding of HDAC3 plays an important role in regulating lipid
homeostasis. Indeed, in chow fed mice in which hepatic HDAC3 was deleted for 2 weeks,
we observed dramatic increase in neutral lipid by Oil Red O staining (Figure 3.15A). In
consistent with this observation, liver triglyceride content was increased by nearly 10
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folds (Figure 3.16B). This was consistent with a fatty liver phenotype of mice depleted of
hepatic HDAC3 in utero [(Knutson et al., 2008)and Figure 3.15C].

REV-ERB mediates the circadian recruitment of HDAC3. Therefore we hypothesized
that loss of Rev-erb in liver also causes steatosis. Indeed, in chow-fed 9 week old
C57Bl/6 mice genetically lacking Rev-erbOil Red O staining of liver was also
increased (Figure 3.16A), and hepatic triglyceride content was nearly double that of WT
mice (Figure 3.16B). Both the HDAC3 liver-specific knockout mice and the Rev-erb
knockout mice show normal serum transaminase activity, indicating little or no liver
damage (data not shown). The relatively modest hepatic steatosis in the Rev-erb
deficient mice likely reflects a role for HDAC3 in mediating effects of other NRs,
including REV-ERB whose circadian expression pattern is similar to that of REVERB (Liu et al., 2008a), but could also reflect a compensatory effect of REV-ERB
depletion in other tissues. Nevertheless the finding that depletion of either REV-ERB
or HDAC3 led to a fatty liver phenotype supports the conclusion that circadian REVERB recruitment of HDAC3 to lipid metabolic genes plays a critical physiological role.

In consistent with increase in lipid content, de novo lipogenesis in mice lacking hepatic
HDAC3 (Figure 3.17A) or in Rev-erb knockout mice (Figure 3.17B) was significantly
elevated. De novo lipogenesis rate was assessed through hepatic palmitate synthesis after
injection of deuterated water. This supports that HDAC3 and REV-suppress
hepatic lipid biosynthesis, and provides a molecular mechanism underlying the
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observation that hepatic lipogenesis in mice follows a diurnal rhythm (Hems et al., 1975)
that is anti-phase to REV-ERB and HDAC3 recruitment to the mouse genome.

3.4 Discussion and Future Directions
Our findings demonstrate the existence of circadian changes in histone acetylation whose
dysregulation has the potential to cause major perturbations in normal metabolic function.
Each day, low concentrations of REV-ERB lead to reduced HDAC3 association with
the liver genome while the organism is active and feeding, altering the epigenome to
permit lipid synthesis and accumulation until abundance of REV-ERB increases
HDAC3 recruitment to liver metabolic genes halts the lipid build-up (Figure 3.18).
When either Rev-erb or HDAC3 is depleted, this cycle does not occur and fatty liver
ensues.

Misalignment of fasting/feeding and sleep/wake cycles with endogenous circadian cycles
could disrupt the rhythm of HDAC3 association with target genes and contribute to the
fatty liver observed in rotating shift workers as well as people with genetic variants of
molecular clock genes (Brunt, 2010; Sookoian et al., 2007).

Although our results suggest that HDAC3 is recruited to the mouse liver genome in a
circadian manner, and that HDAC3 recruitment at many sites is dependent on REVERB, we cannot rule out that other nuclear receptors also play a role in the diurnal
recruitment of HDAC3. Participation of other nuclear receptors is supported by the
observation that mice without HDAC3 exhibited a much more severe fatty liver
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phenotype than mice without Rev-erb. Many other nuclear receptors are expressed in a
similar rhythm as REV-ERB, and can mediate diurnal HDAC3 recruitment. Among
them is nuclear receptor REV-ERB, which has an almost identical DNA binding
domain as REV-ERB. The Rev-erb transcript oscillates almost exactly in phase with
the Rev-erb transcript in liver. In vitro studies showed that REV-ERB recognizes the
same motif and regulates some known REV-ERB target genes. Another candidate
nuclear receptor is PPAR, which shares the same expression rhythm as REV-ERBs in
liver (Yang et al., 2006). Motif analysis of the HDAC3 ZT10 cistrome also revealed a
DR1 nuclear receptor motif known to be bound by PPAR/RXR heterodimer (data not
shown). In addition, Glucocorticoid Receptor has been shown to interact with NCoR. GR
recognizes a distinct motif and is stably expressed in liver (Yang et al., 2006). However,
its genomic binding is regulated by ligands such as corticosterone, and the plasma
corticosterone level is controlled by the circadian clock and is higher at ZT10 (Oster et al.,
2006). Moreover, glucocorticoid has been shown to drive daily oscillation of metabolic
genes in liver (Reddy et al., 2007).

Another question is whether HDAC3 activity is controlled solely by the circadian clock
and REV-ERBs. The answer may be ‘No’. First, previous work in our lab showed that
REV-ERB is subject to post-translational regulation by GSK3 and ubiquitin E3 ligase
ARF-BP/PAM (Yin et al., 2010). This raised the possibility that REV-ERB can be
regulated by environmental cues and adjusts the genomic binding of HDAC3. Secondly,
HDAC3 recruitment by REV-ERB is regulated by heme binding, and heme may serve
as sensor for the intracellular metabolic state (Yin et al., 2007). Furthermore, If HDAC3
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binding is regulated by other nuclear receptors, such as PPAR and GR, it is likely to
respond to fasting/feeding and hormone secretion at the PPAR and GR binding sites. It
may be interesting to separate the HDAC3 bindings that are regulated by the circadian
clock from those regulated by metabolic signals.

In vitro studies showed that REV-ERB regulates target gene expression through both
active and passive repression. In active repression involving NCoR and HDAC3, REVERB binds either a DR2 element as a homodimer or two monomer sites spaced apart. In
passive repression, REV-ERB binds the monomer sites and competes with transcription
activator RORs. Here we reported that REV-ERB actively represses clock and
metabolic genes by recruiting HDAC3 in liver, but motif analysis did not reveal
enrichment of the DR2 element, but instead the monomer motif shared by RORs. The
lack of DR2 element suggest that in most cases, REV-ERB binds to two monomer sites
spaced apart and collaboratively recruit NCoR and HDAC3 as shown in the Bmal1
promoter (Yin and Lazar, 2005). Indeed, a motif scan performed later showed that
approximately 35% of all the REV-ERB binding sites contain at least two half sites and
that many REV-ERB binding sites are located in close proximity to another (less than
2kb) (Bugge et al., 2012). The monomer/ROR motif by the motif analysis suggests that
REV-ERB may repress transcription by directly competing with RORs. And we will
explore passive repression in the next chapter.
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Figure 3.1 Zeitgeber Time. Mice were housed under the regular 12h light/ 12h dark
cycles. Light is on at ZT0 (7am), and off at ZT12 (7pm). ZT10 corresponds to 5pm, and
ZT22 corresponds to 5am.
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Figure 3.2 Diurnal Binding of HDAC3 in Mouse Liver.
A. Overlapping of HDAC3 cistromes at ZT10 (Blue) and ZT22 (Red). A pair of ZT10
and ZT22 binding sites was considered overlapping when their centers were within 200bp
of each other.
B. Heatmap of HDAC3 binding signal at ZT10 (left) and ZT22 (right) from -1kb to +1kb
surrounding the center of all the HDAC3 ZT10 binding sites, ordered by strength of
HDAC3 binding. Each line represents a single HDAC3 binding site and the color scale
indicates the HDAC3 signal (reads encompassing each locus per million total reads).
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C. Average HDAC3 signal from -1kb to +1kb surrounding the center of all the HDAC3
ZT10 binding sites. The Y axis represents the HDAC3 signal per million total reads. ZT,
Zeitgeber time.

61

A

B

C

Figure 3.3 Validation of HDAC3 Binding Sites.
A. Diurnal recruitment of HDAC3 as shown by ChIP-PCR with a different HDAC3
antibody (sc-11417). Six HDAC3 binding sites were interrogated by ChIP-PCR. The
Bmal1 gene promoter was used as a positive control, and regions close to the TSSs of the
Arbp and Ins genes served as negative controls. Values are mean ± s.e.m. (n=4-5).
B. HDAC3 enrichment at HDAC3 binding sites interrogated by ChIP-PCR is largely
diminished upon loss of HDAC3.
C. Depletion of HDAC3 in liver from HDAC3fl/fl mice 1 week after injection of the
AAV-Cre virus. AAV-GFP virus was used as a negative control and protein levels of
HDAC3 and Ran (loading control) were measured by western blot.
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Figure 3.4 Genomic Distribution of HDAC3 ZT10 Cistrome.
A. Distribution of the HDAC3 ZT10 binding sites relative to known genes.
B. Percentage of the HDAC3 ZT10 sites (green) located at different positions relative to
known genes in comparison with the mappable mouse genome (blue). The percentage
was calculated by CEAS as described in Methods, and the p-values indicate the
significance of the differences between the HDAC3 ZT10 cistrome and the mappable
mouse genome.
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Figure 3.5 HDAC3 Binding Oscillates in a 24h Cycle. HDAC3 recruitment at 2
selected genomic sites over a 24h cycle by ChIP-PCR. Immunoprecipitated DNA was
normalized to input. Values are mean ± s.e.m. (n=4-5).
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Figure 3.6 Diurnal Binding of HDAC3 Is Controlled by the Liver Clock.
A. Diurnal HDAC3 genomic recruitment is maintained in constant darkness.

Six

HDAC3 binding sites were assessed by ChIP-PCR (n=4-5). The Bmal1 promoter (Bmal1)
served as a positive control, and regions close to the TSS of the Arbp and Ins genes
served as negative controls.
B. The rhythm of HDAC3 recruitment is reversed by day-time feeding (n=4-5). RF, food
was provided only from ZT3 to ZT11 every day for 2 weeks.
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Figure 3.7 HDAC3 Functions as a Transcription Repressor near Active and
Circadian Genes.
A. HDAC3 binds mainly to active genes. All mouse RefSeq genes were ranked based on
their expression index in ZT10 mouse liver, and genes among the top 10%, middle 10%
and bottom 10% were selected. *p-value~10-279
B. HDAC3 binds mainly to circadian genes. All known genes were divided into circadian
genes and non-circadian genes. The percentage of HDAC3 bound genes in each category
was calculated, and compared with all genes. *p-value~10-136.
C. Genes up-regulated in liver depleted of HDAC3 are significantly enriched for HDAC3
binding at ZT10. Expression arrays of WT and HDAC3 KO liver were performed and
analyzed as described in Methods, and the percentage of HDAC3 bound genes in each
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category was calculated. *p~10-156. p-values were calculated based on hypergeometic
distribution.
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Figure 3.8 Histone Acetylation Is Inversely Correlated with HDAC3 Binding.
A. Heatmap of the histone H3 lysine 9 acetylation (H3K9Ac) signal at ZT22 (left), ZT10
(middle) and ZT10 in liver depleted of HDAC3 (KO) (right) from -1kb to +1kb
surrounding the center of all the HDAC3 ZT10 binding sites. Each line represents a
single HDAC3 binding site and the color scale indicates the H3K9Ac signal per million
total reads. HDAC3 depleted liver was removed from HDAC3fl/fl mice 1 week after
injection of AAV-Cre.
B. Average H3K9Ac signal from -1kb to +1kb surrounding the center of all the HDAC3
ZT10 binding sites. The Y axis represents the HDAC3 signal per million total reads.
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Figure 3.9 Motif Analysis of the HDAC3 ZT10 Cistrome Reveals a Canonical
Nuclear Receptor Half Site. Sequences within ± 300bp from the centers of all the
HDAC3 sites were used for de novo motif analysis (Top) and motif scan against the
JASPAR database (Bottom), and the most enriched motif for each analysis is shown.

69

A

B

HDAC3
REV-ERB
HSP90

REV-ERBEnrichment

C

HDAC3/REV-ERBSites

Figure 3.10 REV-ERBa Cistrome Overlaps with HDAC3 Cistrome at ZT10.
A. Immunoblot of HDAC3 and REV-ERB over a 24h cycle in mouse liver. HSP90
protein levels are shown as loading control.
B. The HDAC3 ZT10cistrome largely overlaps with the REV-ERB ZT10 cistrome.
HDAC3 binding sites and REV-ERB binding sites were considered overlapping when
their centers were within 200bp of each other.
C. REV-ERB enrichment interrogated by ChIP-PCR is largely diminished in Rev-erb
KO liver at ZT10, demonstrating that the REV-ERB antibody is specific.
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Figure 3.11 Genomic Distribution of the REV-ERB ZT10 Cistrome.
A. Distribution of REV-ERB ZT10 sites relative to known genes.
B. Percentage of the REV-ERB ZT10 sites (green) located at different genomic regions
relative to known genes compared with the mappable mouse genome (blue). The
percentage of all sites in each group was calculated by CEAS.
C. Genes up-regulated in Rev-erb KO liver are enriched for both HDAC3 and REVERB binding at ZT10 in mouse liver. Genes up-regulated at ZT12 in the liver of the
Rev-erb KO mouse were identified using published expression array data (Le Martelot
et al., 2009). Among these, the percentage of genes bound by both HDAC3 and REV-

71

ERB were calculated, and compared with all genes. p-values above each column
indicates the significance of difference and were calculated based on hypergeometric
distribution.
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Figure 3.12 REV-ERBRecruits NCoR Corepressor and HDAC3 with a Circadian
Rhythm.
A. HDAC3 (green) ZT10 cistrome largely overlapped with both REV-ERB (red) and
NCoR cistrome at ZT10 (blue). Binding sites were considered overlapping when their
centers were within 200bp of each other. Numbers indicates the percentage of all HDAC3
binding sites in each group.
B. Heatmap of REV-ERB binding at ZT10 and ZT22 (left) and of NCoR at ZT10 and
ZT22 (right), both at HDAC3 ZT10 sites ordered as in Figure 3.2. Each line represents a
single HDAC3/REV-ERB binding site and the color scale indicates the signal per
million total reads.
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Figure 3.13 Loss of HDAC3 and NCoR Recruitment upon Rev-erb Deletion.
A. HDAC3 recruitment to six binding sites in liver from mice lacking Rev-erb was
interrogated by ChIP-PCR.
B. NCoR recruitment to six binding sites in liver from mice lacking Rev-erb was
interrogated by ChIP-PCR. The Bmal1 gene promoter (Bmal1) was used as a positive
control, and regions close to the TSS of the Arbp and Ins genes served as negative
controls. Values are mean ± s.e.m. (n=3).
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Figure 3.14 HDAC3 and REV-ERB Regulate Lipid Metabolic Genes Gene
ontology analysis of the HDAC3 and REV-ERB-bound genes that were up-regulated in
liver depleted of HDAC3 was performed using Panther (Thomas et al., 2003).
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Figure 3.15 Loss of HDAC3 Causes Liver Steatosis.
A. Oil Red O staining of liver from 14 week old HDAC3fl/fl mice 2 weeks after tail vein
injection of AAV-GFP or AAV-Cre.
B. Hepatic triglyceride (TG) levels in mice treated as in “A”. Values are mean ± s.e.m.
(n=4). *p<0.05 by student’s t-test.
C. Enlarged and fatty liver in 8 week old male HDAC3fl/fl/Alb-Cre mice. Livers from
HDAC3fl/fl mice and HDAC3fl/+/Alb-Cre mice are used as negative controls. Alb-Cre, the
cre recombinase gene under a liver-specific Albumin promoter.
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Figure 3.16 Loss of Rev-erb Causes Hepatic Steatosis.
A. Oil Red O staining of liver from 9 week old WT and mice lacking Rev-erb (Reverb KO).
B. Hepatic TG levels in from livers from 9 week old WT and mice lacking Rev-erb
(Rev-erb KO). Values are mean ± s.e.m. (n=4). *p<0.05 by student’s t-test.
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Figure 3.17 Hepatic Lipogenesis Is Upregulated in the Absence of HDAC3 or REVERB.
A. Hepatic de novo lipogenesis (DNL) in 13 week old HDAC3fl/fl mice 1 week after
infection with AAV-Cre or with AAV-GFP. Values are mean ± s.e.m. (n=7-8).
B. Hepatic de novo lipogenesis (DNL) in 14 week old Rev-erb KO mice or WT mice.
Hepatic DNL was measured as newly synthesized and 2H labeled palmitate as in Methods.
Values are mean ± s.e.m. (n=7-8). *p<0.05 by student’s t-test.
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Figure 3.18 Model of REV-ERB and HDAC3 Function in Liver. In the day time,
when mice are inactive and fasting, REV-ERB recruits NCoR/HDAC3, which
deacetylates histone and represses lipid biosynthetic genes. At night, when mice are
active and feeding, REV-ERB is absent, and the dissociation of NCoR/HDAC3 from
the genome allows histone acetylation and transcriptional activation of lipid biosynthetic
genes. Through this mechanism, REV-ERB and HDAC3 contribute to the circadian
oscillation of lipogenesis in liver.
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Table 3.1 List of ChIP-seq Data
total reads

Non-redundant

Rev-Erb 5pm (2 reps)

30,637,929

19,995,375

# of peaks
(SPMR>=1)
30,787

Rev-Erb 5am

12,782,094

11,451,185

984

HDAC3 5pm (3 reps)

42,315,338

28,873,243

14,578

HDAC3 5am (2 reps)

34,786,996

33,139,525

120

NCoR 5pm

18,875,895

18,236,535

23,817

NCoR 5am

16,833,313

16,286,483

5,258

H3K9Ac 5pm
H3K9Ac 5pm after HDAC3
KO
H3K9Ac 5am

12,022,705

NA

122,331 (NPS)

19,904,250

NA

257,421 (NPS)

22,073,824

NA

224,639 (NPS)

5pm Input

20,346,220

16,564,474

NA

5am Input

24,056,755

15,555,656

NA
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Chapter 4
Circadian Regulation of Hepatic Metabolism
by REV-ERB and ROR

Published in part in Genes & Development, 2012, 25(23):2480-8

The text, figures, and legends in this chapter were the work of Dan Feng with the
following exceptions. Experiments on REV-ERB from Figure 4.2 to 4.5 were jointly
conducted by Dan Feng and Anne Bugge, and the figures were plotted by Anne Bugge
except for Figure 4.3B. Experiments from the Genes & Development manuscript that
were conducted solely by Anne Bugge were not included. Bin Fang conducted the
bioinformatics analysis on ROR ChIP-seq. David Steger provided GR ChIP-seq data in
liver. Zheng Sun provided livers from the HDAC3fl/fl mice. Lindsey Peed provided
technical assistance.
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4.1 Abstract
The nuclear receptor REV-ERB regulates circadian rhythm and metabolism. In
particular, REV-ERB, through HDAC3, directs a circadian rhythm of histone
acetylation and gene expression that is crucial for metabolic homeostasis. But Rev-erb
deletion has modest effects on both circadian rhythms and metabolism, and it has been
considered to be a secondary regulator of the cell-autonomous clock. Here we report that
a highly related nuclear receptor REV-ERB binds genome with a circadian rhythm
similar to that of REV-ERB. Depletion of REV-ERB in Rev-erb knockout liver
further decreases HDAC3 recruitment, de-represses clock genes, and exacerbates hepatic
steatosis. Loss of both REV-ERBs completely abolishes the circadian rhythm, as shown
in mouse embryonic fibroblasts. These findings establish the two REV-ERBs as major
regulators of both clock function and metabolism. In addition to HDAC3, REV-ERBs can
passively repress gene expression by competing with RORs. We report that ROR binds
Bmal1 and Npas2 genes with a diurnal rhythm anti-phase to that of REV-ERBs. REVERBs represses ROR binding at ZT10 and thus drives the diurnal recruitment of ROR,
which is expressed at a constant levelRepression by REV-ERBs is independent of
HDAC3, suggesting that REV-ERBs represses ROR binding through direct competition.
We identify thousands of competing sites similar to those in Bmal1 and Npas2 genes by
ROR ChIP-seq at ZT10 and ZT22, many of which are in close proximity of clock and
metabolic genes. Functions of ROR in liver will be tested in mouse models of liverspecific deletion of ROR and its paralog ROR. We also discover thousands of ROR
binding sites with little or no difference in ROR binding between ZT10 and ZT22, and
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sites where ROR binds in phase with REV-ERBs. How ROR recruitment is regulated
at these non-competing or in-phase sites remains to be elucidated.

4.2 Introduction
4.2a REV-ERB
In Chapter 3, we show a circadian rhythm of REV-ERB binding at thousands of
genomic sites, which is consistent with the dramatic oscillation of REV-ERB protein.
We also show that REV-ERB recruits the NCoR corepressor complex and HDAC3, and
drives the circadian oscillation of histone acetylation and gene expression. We discovered
that REV-ERB and HDAC3 binding are enriched near lipid metabolic genes, and that
loss of Rev-erb or HDAC3 leads to hepatic steatosis. However, loss of Rev-erb has
minor effects in comparison with loss of HDAC3, raising the question whether other
nuclear receptors also play a role in recruiting HDAC3 and suppressing hepatic lipid
biosynthesis.

Loss of Rev-erb also has a modest effect on circadian rhythm (Preitner et al., 2002).
Although the circadian expression of Bmal1 and Clock is severely blunted in the liver of
the Rev-erb-deficient mice, the circadian expression of Cry2 and Per2 are almost intact.
When these mice were put into constant darkness, they maintained circadian locomoter
activity, suggesting that the circadian rhythm was not disrupted, though the circadian
period is slightly yet significantly shorter in these mice (Preitner et al., 2002). These
findings argue that REV-ERB only plays an auxiliary role in the circadian clock.

83

However, the basic clock machinery is featured by the redundancy of its components
(DeBruyne et al., 2007; van der Horst et al., 1999; Shi et al., 2010; Zheng et al., 2001).
Therefore, we hypothesized that a closely related nuclear receptor REV-ERB can
compensate for loss of REV-ERB, and the REV-ERBs are essential components of the
core clock.

Like REV-ERB, REV-ERB is also considered an orphan nuclear receptor (Retnakaran
et al., 1994). It is the most closely related nuclear receptor to REV-ERB (>95%
identical in the DNA binding domain, and >65% identical in the ligand binding domain).
Only estrogen receptors (ERs) have a similar high degree of conservation at the DNA
binding domain among the two subtypes. The REV-ERBs differ in the N-terminal A/B
domain and the hinge region. REV-ERB also recognizes the canonical REV-ERB
motif, which is an AGGTCA half site preceded by an A/T-rich sequence at the 5’ (Dumas
et al., 1994; Pardee et al., 2009; Woo et al., 2007) (Figure 4.1). Rev-erb is also
ubiquitously expressed, and has been shown to regulate Bmal1 and ApoC-III, the known
targets of REV-ERB (Liu et al., 2008a; Wang et al., 2007, 2008), as well as genes
involved in lipid absorption in skeletal muscle cells (Ramakrishnan et al., 2005). Like
REV-ERB, REV-ERB also binds heme, which enhances corepressor recruitment and
transcriptional repression (Pardee et al., 2009; Raghuram et al., 2007). Through heme,
REV-ERBs can sense the redox state and gas such as O2, NO and CO (Pardee et al.,
2009). In addition, heme binding can be regulated by the redox state of the REV-ERB
protein (Gupta and Ragsdale, 2011). Other than the above findings, little is known about
the role of REV-ERBin circadian rhythms and metabolism.
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4.2b RORs
The ROR subfamily of nuclear receptors consists of three members: ROR (NR1F1),
ROR (NR1F2) and ROR (NR1F3). They are classified as orphan receptors, and their
endogenous ligands are yet to be discovered. Each ROR gene generates several different
transcripts by using different promoters and/or through alternative splicing, and produces
isoforms that differ in the N-terminal protein. Each ROR gene and isoform has its own
distinct profile of tissue-specific expression (reviewed in Jetten, 2009). For instance,
ROR4 and ROR1 are expressed in liver, and ROR2 (RORt) is expressed specifically
in T cells (Chauvet et al., 2002; He et al., 1998).

RORs have a typically nuclear receptor structure that contains an N-terminal A/B domain,
a DNA binding domain, a hinge region and a ligand binding domain. It binds as a
monomer to the ROR response element, which consists of an AGGTCA nuclear receptor
half site preceded by an A/T-rich sequence (Carlberg et al., 1994; Forman et al., 1994;
Giguère et al., 1994; Medvedev et al., 1996). The DNA binding domain of RORs is 65%
homologous to that of REV-ERBs, the highest among all nuclear receptor subfamily
(Forman et al., 1994). In consistent with the high homology, RORs have been shown to
compete with REV-ERBbinding in vitro (Forman et al., 1994), and to regulate the clock
genes including Bmal1 and Npas2 through the same binding sites as REV-ERBs (Akashi
and Takumi, 2005; Crumbley et al., 2010; Guillaumond et al., 2005; Takeda et al., 2011)
(Figure 4.1).
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Unlike REV-ERBs, RORs have Helix 12, which allows them to interact with coactivators,
including SRC-1, SRC-2, PGC-1a, p300 and CBP (reviewed in Jetten, 2009). Particularly,
ROR activates G6pase expression by recruiting SRC-2 and regulates hepatic glucose
production (Chopra et al., 2008). RORs also interact with corepressors, including NCoR
and SMRT (reviewed in Jetten, 2009). The transcriptional activity of RORs can be
regulated by several agonists and antagonists. For instance, 7-oxygenated sterol and 24Shydroxycholesterol functions as inverse agonists for RORs by inhibiting coactivator
recruitment, while a few other hydroxycholesterol functions as agonists by promoting
coactivator recruitment (Jin et al., 2010; Wang et al., 2010a, 2010b).

RORs play an important role in a variety of physiological processes, including circadian
rhythms, metabolism and inflammation (reviewed in Jetten et al., 2013). Genetic ablation
of ROR or ROR causes aberrant circadian behaviors as measured by lomocotor
activity (Akashi and Takumi, 2005; André et al., 1998). ROR and ROR have been
shown to regulate Bmal1 and Npas2 expression (Akashi and Takumi, 2005; Crumbley et
al., 2010; Guillaumond et al., 2005; Takeda et al., 2011). ROR1 expression is directly
regulated by BMAL1/CLOCK, and exhibits a circadian pattern (Mongrain et al., 2008;
Takeda et al., 2012). In metabolism, genetic ablation of ROR downregulates a number
of lipid metabolic genes, and prevents age- or diet-induced liver steatosis (Kang et al.,
2007; Lau et al., 2008; Raspé et al., 2001). In addition to hepatic lipid metabolism, RORs
are also involved in glucose metabolism, insulin sensitivity, and metabolism in adipose
tissue and muscle (reviewed in Jetten, 2009; Jetten et al., 2013).
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4.3 Results
4.3a

REV-ERB

Protects

Circadian

Rhythms

and

Metabolic

Homeostasis from Loss of Rev-erb
We hypothesized that REV-ERB protects the circadian clock and metabolic homeostasis
in the Rev-erb deficient mice, which accounts for the modest effects of Rev-erb
deficiency. REV-ERB is known to bind the same response elements as REV-ERB in
vitro. Previous studies in our lab revealed that 92% of the REV-ERB ZT10 cistrome
overlapped with the REV-ERB ZT10 cistrome and that the REV-ERB binding signals
were highly correlated with that of REV-ERB (r=0.78) (Bugge et al., 2012). The
cistromic study indicated that REV-ERB shares many gene targets as REV-ERB.
Gene ontology analysis of genes with at least one shared binding site within 10kb from
their TSSs revealed enrichment for metabolic processes, within lipid metabolism among
the top three specialized pathways (Bugge et al., 2012).

Indeed REV-ERB was expressed with a circadian rhythm similar to the rhythm of REVERB. Rev-erb mRNA reached its peak around ZT10/5pm, and reached its trough at
between ZT18/1am and ZT2/9am (Figure 4.2A), which was consistent with its protein
(Bugge et al., 2012). Its peak lagged slightly behind that of Rev-erb, which is between
ZT6/1pm and ZT10/5pm. The genomic binding of REV-ERB was highly correlated
with its expression level, as shown in the Bmal1 promoter and the Npas2 promoter
(Figure 4.2B). REV-ERB showed the strongest binding between ZT10/5pm and
ZT14/9pm, while REV-ERB shows the strongest binding at ZT10/5pm (Figure 4.2C).
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The similar diurnal rhythm and the strong correlation of REV-ERB and REV-ERB
binding in mouse liver support that Rev-erb represses many of the same genes as REVERB at the same time of the day.

To test this hypothesis, we depleted hepatic REV-ERB using an adenovirus encoding a
shRNA sequence targeting Rev-erb (adeno-shRev-erb). Rev-erb mRNA and protein
levels were down-regulated by at least 80% one week after virus injection [Figure 4.3A
and (Bugge et al., 2012)]. In Chapter 3, we showed that REV-ERB recruited the NCoR
corepressor complex and HDAC3 to repress target genes, and observed residual NCoR
and HDAC3 binding upon loss of Rev-erb. Here we showed that loss of REV-ERB
also decreased HDAC3 binding at the Bmal1 promoter by approximately 50%,
comparable to that in the Rev-erb knockout mice (Figure 4.3B). More importantly,
deficiency of both REV-ERBs further decreased HDAC3 binding (Figure 4.3B),
indicating that upon loss of either REV-ERB, the remaining one mediates the residual
recruitment of HDAC3 and continually represses the shared targets. In consistent with the
loss of HDAC3 binding, Bmal1 is elevated upon loss of REV-ERB, and is further
elevated upon loss of both REV-ERBs (Figure 4.3A). At the promoter of Npas2, neither
depletion of REV-ERB or knockout of Rev-erb significantly lowered HDAC3 binding
(Figure 4.3B), which explained the minimum change in Npas2 expression (Figure 4.3A).
However, deficiency of both REV-ERBs downregulated HDAC3 binding by
approximately 50% (Figure 4.3B), leading to a dramatic increase in Npas2 expression
(Figure 4.3A). In this case, one REV-ERB can almost completely compensate for loss of
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the other. These findings may explain the modest effects of Rev-erb knockout in both
circadian rhythms and metabolism.

To test the hypothesis that REV-ERB protects the liver from steatosis upon loss of Reverb, we measured the triglyceride content in the REV-ERB/ depleted liver. One week
after injection of adeno-shRev-erb, hepatic lipid content in the Rev-erb knockout liver
was further elevated (Figure 4.4A). Increase in hepatic lipid content was also confirmed
by Oil Red O staining for neural lipid (Figure 4.4B).

To test the hypothesis that REV-ERB protects the circadian rhythm upon loss of Reverb, we isolated mouse embryonic fibroblasts (MEFs) from both wildtype and Rev-erb
knockout mice, and treated them with adeno-shRev-erb. Upon serum shock, MEFs with
normal REV-ERB levels were synchronized and displayed circadian oscillation of the
clock genes, including Bmal1 and Cry1. Oscillation of Bmal1 and Cry1 was maintained
when either REV-ERB was depleted, and was completely abolished when both REVERBs were depleted, proving that REV-ERB is protecting the circadian clock in the
absence of REV-ERB. REV-ERBs are essential components of the core clock
machinery.

In conclusion, we discovered that REV-ERB displays circadian genomic binding similar
to REV-ERB and that REV-ERB shares many genomic binding sites and target genes
with REV-ERB. Moreover, both REV-ERBs repress gene transcription by recruiting
HDAC3, and are key regulators of the circadian clock and lipid metabolism. The
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redundancy of REV-ERB and REV-ERB protects circadian rhythms and metabolism,
and deficiency of both REV-ERBs abolishes circadian rhythms and disrupts metabolic
homeostasis.

4.3b REV-ERBs Compete with ROR for Genomic Binding at the
Clock Genes
We hypothesized that REV-ERBs repress many clock and metabolic genes by directly
competing with ROR for genomic binding adjacent to these genes, and that competition
with ROR is crucial for maintaining the circadian rhythm and metabolic homeostasis.
We first tested this hypothesis at the promoters of two clock genes, Bmal1 and Npas2.
Previous studies already showed that REV-ERB binds these promoters in a circadian
manner, with a peak at ZT10 and a trough at ZT22. ROR bound the Bmal1 promoter
and the Npas2 promoter at ZT22, when both REV-ERBs are absent in liver (Figure 4.6A).
At ZT10, when REV-ERBs occupy these promoters, ROR binding were largely
inhibited (Figure 4.6A). The anti-phase rhythm of ROR binding to these promoters,
despite of the constant expression of ROR(Figure 4.6B), supports the idea that REVERBs compete with and repress RORbinding. Indeed, ROR binding at the Bmal1
promoter was significantly upregulated when Rev-erb was deleted genetically or when
REV-ERB was depleted by injection of adeno-shRev-erb, and was dramatically upregulated in the absence of both Rev-erbs, to a level close to that at ZT22 (Figure 4.7A),
but no change was observed in the ROR protein level (data not shown). At the Npas2
promoter, significant upregulation of ROR binding was only observed in the absence of
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both Rev-erbs (Figure 4.7A). Changes in ROR binding were consistent with increase in
gene expression (Figure 4.3A). Moreover, ROR binding showed no increase when
HDAC3 was deleted in the liver and Rev-erb binding was unaffected (Figure 4.7B),
suggesting that REV-ERBs suppress ROR binding through direct competition,
independent of chromatin modification (Figure 4.7C).

4.3c Genome-wide Profile of ROR Binding
We hypothesized that the competition between REV-ERBs and ROR is not limited to
Bmal1 and Npas2, but is a genome-wide phenomenon. To test this hypothesis, we
performed ROR ChIP-seq in mouse liver harvested at ZT10 and ZT22. We performed
peak calling using HOMER, and identified approximately 13,600 ROR binding sites at
ZT10, and approximately 20,000 ROR binding sites at ZT22 (Figure 4.8A). Almost all
of the ROR cistrome (including binding sites at ZT10 and ZT22) was also bound by
REV-ERB(Figure 4.8B). We then normalized the ROR signal to the total number of
reads in each dataset, and compared the ROR signal at ZT10 and ZT22 (Figure 4.9A).
We successfully identified 4740 competing sites where ROR binding increases by at
least 1.5 fold from ZT10 to ZT22. Many of the competing sites located near clock genes
including Bmal1, Npas2 and Cry1, metabolic genes including G6pase, Elovl5, Gpam and
Hmgcs2, and metabolic regulators including PGC-1, E4bp4 and Insig2 (data not shown).
The competing sites are only a small fraction of the ROR cistrome. We also identified
7520 non-competiting sites (less than 1.2 fold difference between ZT10 and ZT22) and
2486 in-phase sites (at least 1.5 fold decrease from ZT10 to ZT22). Among the
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competing sites are the Bmal1 promoter (Figure 4.9B) and the Npas2 promoter. ROR
binding at six selected binding sites was validated with ChIP-PCR (Figure 4.10A) and
also with another ROR antibody recognizing a different epitope (Figure 4.10B).
Binding sites 1-3 are competing sites, and binding sites 4-6 are non-competing sites. All 6
bindings are indeed specific to ROR, as ROR binding at these sites was significantly
decreased in the ROR sg/sg mice carrying a nonsense mutation in the ROR gene
(Figure 4.10C, D).

We then compared REV-ERB binding at the competing sites, non-competing sites and
in-phase sites, and found that REV-ERB binding oscillated with similar amplitudes in
all three groups (Figure 4.9C). To understand the mechanisms that account for different
RORbinding rhythms, we performed de novo motif analysis on the competing sites
using the non-competiting sites as control. The top two motifs found were a DR2 nuclear
receptor motif, which is a direct repeat of the nuclear receptor half sites separated by two
nucleotides and a canonical ROR/REV-ERB motif, which is a nuclear receptor half
site preceded by A/T-rich sequence (Figure 4.11A). Both motifs occurred at a
significantly higher frequency in the competing sites compared with the non-competing
or in-phase sites (Figure 4.11B). They were also significantly enriched near the center of
the ROR peaks, and the enrichment was much higher in the competing sites (Figure
4.11C, D). These findings suggest that competition between ROR and REV-ERBs is
more likely to occur at genomic regions with desired DNA sequences and high affinity
for ROR and REV-ERBs, and agree with our hypothesis that ROR and REV-ERBs
compete for the same binding motif in vivo. Moreover, the DR2 motif was enriched at the
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center of the competing sites, but barely at the center of non-competing or in-phase sites
(Figure 4.11D). This may be explained by the in vitro finding that REV-ERB binds the
DR2 motif as a homodimer, 5 to 10 times more stable than REV-ERB monomer
binding to the ROR motif (Harding and Lazar, 1993). The strong binding at the DR2
motif by REV-ERBs can better prevent ROR binding.

4.3d Overexpression of ROR

Fails to Overcome REV-ERB

Competition
To further test the hypothesis that REV-ERBs suppress ROR binding through direct
competition, we overexpressed ROR4, the dominant ROR isoform in liver, using an
adeno-associated virus encoding the ROR4 cDNA (AAV-ROR4). Two weeks after
virus injection, we observed a 15 fold increase in the ROR4 transcript (Figure 4.12A).
ROR4 overexpression increased ROR binding at ZT22 at all four binding sites when
Rev-erb is absent, including two new sites identified by ChIP-seq (Figure 4.12B), but
failed to overcome REV-ERB suppression at ZT10 at Bmal1, Npas2 and the ROR
binding site 3, a competing site. In consistent with unchanged ROR binding, ROR4
overexpression failed to induce Bmal1 or Npas2 expression at ZT10 (Figure 4.12A). Our
results suggest that REV-ERBs might have a higher affinity for the competing sites, and
dominate in the competition with ROR. At the ROR binding site 4, a non-competing
site, the increased ROR level doubled the ROR binding at both ZT10 and ZT22
(Figure 4.12B), supporting our model that REV-ERBs do not compete with RORat
these sites.
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4.3e ROR Binding Correlates with Histone Acetylation
Nuclear receptors regulate transcription through recruiting coactivator and corepressor
complexes. Coactivator complexes usually contain histone acetyltransferases (HATs),
such as p300 and CBP. ROR has been shown to recruit p300 in muscle and coactivator
SRC-2 in liver (Chopra et al., 2008; Lau et al., 1999). We discovered that p300
recruitment to the ROR binding sites correlates with the rhythmic ROR binding
(Figure 4.13A). We observed rhythmic p300 recruitment only at the competing sites, but
not at the non-competing sites. Moreover, the rhythmic p300 recruitment at the
competing sites may allow a more robust oscillation in histone acetylation, in comparison
with the non-competing sites (Figure 4.13B). Our findings suggest that in addition to
HDAC3 recruitment, REV-ERBs may also control histone acetylation by repressing
ROR-mediated recruitment of p300. 

4.4 Discussion and Future Directions
In consistent with our finding that REV-ERB protects circadian rhythms in the absence
of REV-ERB, Evans and colleagues showed that Rev-erb and Rev-erb double
knockout mice become arrhythmic in constant darkness. So far every single component
of the core clock machinery has been deleted genetically in mouse. Except for Bmal1
deletion (Bunger et al., 2000), none of the single mutation rendered mice arrhythmic in
constant darkness, though most of them did affect the rhythm to some extent (Cermakian
et al., 2001; DeBruyne et al., 2006; Dudley et al., 2003; van der Horst et al., 1999;
Vitaterna et al., 1999; Zheng et al., 1999, 2001). Even the Bmal1 deletion can be
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compensated by ectopic expression of Bmal2 (Shi et al., 2010). In contrast,
combinational deletion of the redundant components completely abolished the circadian
rhythms, such as the double deletion of Clock and Npas2, Cry1 and Cry 2, Per1 and Per2,
and Rev-erb and Rev-erb (Bae et al., 2001; Cho et al., 2012; DeBruyne et al., 2007;
van der Horst et al., 1999; Vitaterna et al., 1999; Zheng et al., 2001). Together, these
studies demonstrate the unusual redundancy of the core clock components. The circadian
rhythm is so critical for survival that every component in the clock machinery needs a
backup.

Although the paralogs in the circadian clock are redundant in maintaining circadian
rhythms, they may be regulated differently and have different functions in circadian
outputs. Our study showed that REV-ERB and REV-ERB have almost identical
genomic binding profiles and rhythms and a similar role in preventing hepatosteatosis.
But they may behave differently in response to environmental signals. It may be
interesting to see if the Rev-erb-deficient mice and the Rev-erb-deficient show
different response to light exposure or fasting/feeding. Also we should look into other
tissues to see if the two REV-ERBs have different roles in regulating other physiological
activities.

We identified three different types of ROR binding sites based on their binding rhythms:
the competing sites, the non-competing sites and the in-phase sites. For the competing
sites, as represented by the Bmal1 promoter and the Npas2 promoter, we showed that
REV-ERBsrepress ROR binding at ZT10 and drive a rhythmic ROR binding in
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mouse liver. These binding sites are more likely to contain the ROR motif and the
REV-ERB DR2 motif, suggesting that competition happens in the genomic region with
desired DNA sequences that allow specific and strong binding of ROR and REV-ERB.
We also discovered that rhythmic ROR binding correlates with p300 recruitment and
contributes to the robust oscillation of histone acetylation at the competing sites. Our
findings all agreed with our hypothesis that REV-ERBs drive circadian histone
acetylation and gene expression through competing with ROR. We still need to address
whether p300 recruitment is dependent on ROR.

So far, we have not addressed the biological significance of ROR. Previous studies in
our lab showed that loss of HDAC3 does not abolish circadian rhythms as tested in MEFs
and in liver (data not shown). Since the active repression model cannot account for all the
activities of REV-ERBs, we hypothesized that passive repression through RORalso
plays an important role in regulating circadian rhythms and metabolic activities. In
consistent with our hypothesis, we found competing sites near clock genes including
Bmal1, Npas2 and Cry1, metabolic genes including G6pase, Elovl5, Gpam and Hmgcs2,
and metabolic regulators including PGC-1, E4bp4 and Insig2 (data not shown).
Disregulation of circadian and metabolic gene expression has been shown in the livers of
the ROR sg/sg mice (Kang et al., 2007; Takeda et al., 2012). However, these mice
suffer from severe impairment of orientation and motor capabilities and have significant
lower weight compared to the WT mice, and therefore are not a good model to study the
function of ROR in circadian rhythms and liver metabolism. Instead, we will use a
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ROR conditional knockout model and delete ROR specifically in liver by injection of
the AAV-Cre virus.

ROR1 is also expressed in liver, and its transcript level is comparable to that of
ROR(data not shown). Unlike ROR, ROR1 shows circadian expression at the
transcript level, which has not been validated at the protein level (Mongrain et al., 2008).
Given that ROR1 is expressed anti-phase to REV-ERBs, competition between REVERBs and ROR1 may not exist or has little effect on ROR1 activity. However, ROR1
may compensate for the loss of ROR in liver. Therefore we will cross the ROR
conditional knockout mice with the ROR conditional knockout mice to generate the
ROR/ROR double conditional knockout mice to test the function of RORs in circadian
rhythms and metabolism. Moreover, we may also discover non-overlapping functions of
ROR and ROR

So far our studies have been focusing on the competing sites. However, it is also
important to understand why REV-ERBs do not compete with ROR at the noncompeting sites. ChIP-PCR showed relatively weak but real binding of RORat the noncompeting sites (Figure 4.10), and binding was doubled upon ROR overexpression at
both ZT10 and ZT22. There may be two explanations for our observations. First, REVERBs and RORmay bind to two different motifs adjacent to each other. We can test
this hypothesis by measuring the peak distance between the overlapping ROR and
REV-ERB binding sites in the non-competing sites and comparing it to that in the
competing sites. We can also try to identify multiple nuclear receptor motifs within the
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non-competing sites. The second explanation is that the non-competing sites contain less
than perfect motifs and have an open chromatin structure so that nuclear receptors like
ROR and REV-ERBs can bind to them transiently and do not compete with each other.
But such transient binding may not be important for gene regulation.

It is also intriguing that ROR is recruited in-phase with REV-ERBs at many sites and
that these sites are significantly enriched for GR motif (Figure 4.11B, E). Obviously we
need to validate the ROR binding at these sites. But it is interesting to see that GR
binding is indeed enriched at these sites compared with the competing and noncompeting sites (Figure 4.14). GR is stably expressed in liver, but its genomic binding
and transcriptional activity is regulated by ligands, such as corticosterone. The plasma
corticosterone level fluctuates with a peak between ZT10 and ZT14 and a trough between
ZT20 and ZT24 (Oster et al., 2006). This explains our finding that GR binds to the mouse
liver genome with a rhythm that is high at ZT10 and low at ZT22 (data not shown). We
thus hypothesized that GR contributes to the in-phase binding of ROR. It is known that
daily injection of glucocorticoid can drive the oscillation of 60% of the circadian
transcriptome in liver, and it is possible that ROR is involved in this process. Once we
validate the in-phase binding of ROR, we can test the GR hypothesis by activating GR
binding at ZT22 with dexamethasone injection.

We reported that competition exists between REV-ERBs and ROR, but it may also exist
between REV-ERBs and another nuclear receptor, such as PPAR, or between two other
nuclear receptors. Mandrup and colleagues recently reported that PPAR binds to over
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70% of the LXR sites in mouse liver, and binding of PPAR and LXR are mutually
exclusive (Boergesen et al., 2012). Therefore, it may be interesting to compare the ROR
cistrome and the REV-ERB cistrome we have with the public available cistromes of other
nuclear receptors.

Recent advances in the next generation sequencing technology allowed scientists to
accurately map the genome-wide binding of a large number of transcription factors in a
variety of cell lines and tissues from different organisms. Comparing the transcription
factor maps led to surprising findings that transcription factor binding is highly tissuespecific, and that in the same tissue or cell line, many transcription factors share a large
number of genomic regions. For instance, Mandrup and colleagues recently reported that
CEBP, STAT5a and GR co-occupy ‘hotspots’ characterized by an open chromatin
structure and specific epigenetic modifications in early adipogenesis (Siersbæk et al.,
2011). Pu and colleagues showed that several cardiac transcription factors, including
GATA4, NKX2-5, MEF2A, TBX5 and SRF, co-occupy many genomic regions (He et al.,
2011). Ng and colleagues discovered hundreds of multiple-transcription factor binding
sites in embryonic stem cells (Chen et al., 2008). The modENCODE consortium reported
high occupancy target (HOT) regions that are occupied by at least 15 transcription factors
in C. elegans or by at least 8 transcription factors in Drosophila (Gerstein et al., 2010;
Nègre et al., 2011). The molecular mechanisms and the biological significance of cooccupancy by transcription factors remain to be explored.
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Figure 4.1 REV-ERBs and RORs Share Many Genomic Binding Sites. REV-ERBs
and RORs recognize the same binding motif and share many gene targets including
Bmal1 and Npas2.
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Figure 4.2 Circadian Expression and Genomic Binding of REV-ERB in Mouse
Liver.
A. Rev-erb and Rev-erb mRNA levels in the livers of 12 week old C57Bl/6 mice
housed in a 24h cycle. Values are mean ± s.e.m (n=5).
B. REV-ERB recruitment at the Bmal1 promoter and the Npas2 promoter over a 24h
cycle as interrogated by ChIP-PCR. Immunoprecipitated DNA was normalized to input.
Values are mean ± s.e.m (n=3-4).
C. REV-ERB recruitment at the Bmal1 promoter and Npas2 promoter over a 24h cycle
as interrogated by ChIP-PCR. Values are mean ± s.e.m (n=3-4).
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Figure 4.3 REV-ERB Compensates for Loss of REV-ERB and Represses Clock
Genes.
A. Gene expression in livers from 12 week old male WT or Rev-erb knockout ()
mice one week after injection of adeno-shRev-erb (shRev) or adeno-shGal (shGal)
as control. Values are mean ± s.e.m (n=4-6). *p<0.05 by student t-test.
B. HDAC3 recruitment in livers as in A as interrogated by ChIP-PCR. Values are mean ±
s.e.m (n=3). *p<0.05 by student t-test.
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Figure 4.4 REV-ERB Prevents Liver Steatosis from Loss of REV-ERB.
A. Hepatic TG levels in livers from 12 week old male WT or Rev-erb knockout ()
mice one week after injection of adeno-shRev-erb (shRev) or adeno-shGal (shGal)
as control. Values are mean ± s.e.m (n=5-7). *p<0.05 by student t-test.
B. Oil Red O staining of liver from 12 week old male WT or Rev-erb knockout ()
mice one week after injection of adeno-shRev-erb (shRev) or adeno-shGal (shGal)
as control.
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Figure 4.5 REV-ERB Protects the Circadian Clock from Loss of REV-ERB.
Gene expression in synchronized WT or Rev-erb knockout (KO) MEFs infected with
adeno-shRev-erb (shRev) or adeno-shGal (shGal) as control. Values are mean ±
s.e.m (n=3). All values have been normalized to Arbp expression and the 8 hr time point
in the WT control.
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Figure 4.6 Diurnal Binding of ROR
A. Diurnal recruitment of ROR to the Bmal1 promoter and the Npas2 promoter was
shown by ChIP-PCR. The region close to the TSS of the Arbp gene served as a negative
control. Values are mean ± s.e.m. (n=4-5).
B. ROR mRNA levels in the livers of 12 week old C57Bl/6 mice housed in a 24h cycle.
Values are mean ± s.e.m (n=5).
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Figure 4.7 REV-ERBs Repress ROR Binding.
A. ROR recruitment to the Bmal1 promoter and the Npas2 promoter was upregulated in
the absence of REV-ERB and/or REV-ERB. ROR recruitment in livers from 12
week old male WT or Rev-erb knockout () mice one week after injection of adenoshRev-erb (shRev) or adeno-shGal (shGal) was interrogated by ChIP-PCR. Values
are mean ± s.e.m (n=4-5). *p<0.05 by student t-test.
B. ROR recruitment to the Bmal1 promoter and the Npas2 promoter was unaffected in
the absence of HDAC3. REV-ERB and ROR recruitment in livers from the HDAC3fl/fl
mice 1 week after injection of the AAV-Cre virus was interrogated by ChIP-PCR. AAVGFP virus was used as a negative control. Values are mean ± s.e.m (n=4).
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Figure 4.8 ROR Cistrome in Liver at ZT10 and ZT22.
A. Comparison of HDAC3 binding sites at ZT10 (Blue) and ZT22 (Red). Peak calling
was performed with HOMER. A pair of ZT10 and ZT22 binding sites (approximately
200bp wide) was considered overlapping when they have at least 1bp in common.
B. Heatmap of ROR and REV-ERB binding signal at ZT10 and ZT22 from -1kb to
+1kb surrounding the center of all the ROR and REV-ERB binding sites. Each line
represents a single binding site and the color scale indicates the binding signal (read
density in ChIP-seq data).
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Figure 4.9 Identify Competing, Non-competing and In-phase Binding Sites.
A. Scatter plot of ROR binding signals at ZT10 (x-axis) and ZT22 (y-axis) in log scale.
Competing (Red), no-competing (Blue) and in-phase (Green) sites were identified based
on the fold changes of signals from ZT10 to ZT22.
B. The Bmal1 promoter was identified as a competing site. Peak height correlates with
the REV-ERB (Red) or ROR (Green) ChIP-seq signal at ZT10 or ZT22.
C. Average ROR and REV-ERB binding signals surrounding the center of the
competing, non-competing and in-phase sites at ZT10 and ZT22. The signals were
represented by the read density in ChIP-seq data.
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Figure 4.10 Validation of ROR Binding Sites.
A. B. ROR recruitment at ZT10 and ZT22 as shown by ChIP-PCR with two different
ROR antibodies C-16 (A) and H-65 (B). Six ROR binding sites were interrogated,
including 3 competing sites (1-3) and 3 non-competing sites (4-6). The Bmal1 gene
promoter and the Npas2 promoter were used as positive controls, and the region close to
the Arbp TSS as a negative control. Values are mean ± s.e.m. (n=4).
C. D. ROR recruitment at ZT22 in livers from WT mice or the ROR sg/sg mice as
shown by ChIP-PCR with two different ROR antibodies C-16 (C) and H-65 (D).

110

A

ROR motif
DR2 motif

C

35
30
25
20
15
10
5
0

3.0E-03

Competing

2.5E-03

Non-competing

2.0E-03

In-phase

1.5E-03
1.0E-03
5.0E-04
0.0E+00

ROR

D
6.0E-04
Sites per bp per peak

ROR
Sites per bp per peak

B

DR2

DR2

GR

-1000 -600 -200 200 600 1000

E

5.0E-04
4.0E-04
3.0E-04
2.0E-04
1.0E-04
0.0E+00
-1000 -600 -200 200 600 1000

2.0E-03
Sites per bp per peak

% of binding sites with motif

GR motif

GR

1.6E-03
1.2E-03
8.0E-04
4.0E-04
0.0E+00
-1000 -600 -200 200 600 1000

Figure 4.11 Motif Analysis of the ROR Binding Sites.
A. Three motifs identified in motif analysis of the competing, non-competing and inphase binding sites.
B. Percentage of bindings sites with either ROR, DR2 or GR motif as shown in A
among the competing (Red), non-competing (Yellow) and in-phase (Green) binding sites.
C. D. E. Density of the ROR (C), DR2 (D) and GR (E) motif surrounding the center of
the competing (Red), non-competing (Yellow) and in-phase (Green) binding sites.
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Figure 4.12 Overexpression of ROR Fails to Overcome REV-ERB Competition.
A. ROR, Bmal1 and Npas2 expression in livers harvested at ZT10 and ZT22 from 12
week old C57Bl/6 mice 2 weeks after injection of AAV-ROR4 or AAV-GFP (control).
Values are mean ± s.e.m (n=3).
B. ROR recruitment in livers harvested at ZT10 and ZT22 from 12 week old C57Bl/6
mice 2 weeks after injection of AAV-ROR4 or AAV-GFP (control). Values are mean ±
s.e.m (n=3). *p<0.05; #p~0.05.
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Figure 4.13 ROR Binding Is Associated with p300 Recruitment and Histone
Acetylation.
A. p300 recruitment at ZT10 and ZT22 as shown by ChIP-PCR at six ROR binding
sites, including 3 competing sites (1-3) and 3 non-competing sites (4-6). The Bmal1 gene
promoter and the Npas2 promoter were used as positive controls, and the region close to
the Arbp TSS as a negative control. Values are mean ± s.e.m. (n=4).
B. Average H3K9Ac signal from -2kb to +2kb surrounding the center of all the
competing (Left) and non-competing sites (Right). The Y axis represents the H3K9Ac
signal (read density).
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Figure 4.14 In-phase ROR Binding sites Are Enriched for GR binding. Average
GR binding signal at ZT10 from -1kb to +1kb surrounding the center of all the competing
(Red), non-competing sites (blue) and in-phase (Green) sites. The Y axis represents the
GR signal (read density).
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Chapter 5
Future Directions
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5.1 Summary
My study suggests that REV-ERB and REV-ERB direct a circadian rhythm in histone
acetylation and gene expression that is required for hepatic homeostasis in liver, by
recruiting histone deacetylase HDAC3 or suppressing ROR and histone acetylase
recruitment. In Chapter 3, I showed that histone deacetylase 3 (HDAC3) recruitment to
the genome displays a circadian rhythm in mouse liver. Histone acetylation is inversely
correlated to HDAC3 binding, and this rhythm is lost in the absence of HDAC3.
Although protein amounts of HDAC3 are constant in liver, its genomic recruitment
corresponds to the expression pattern of the circadian nuclear receptor REV-ERB. I
demonstrated that REV-ERB is required for HDAC3 recruitment at many HDAC3
binding sites. I found that REV-ERB colocalizes with HDAC3 near genes regulating
lipid metabolism, and deletion of HDAC3 or REV-ERB in mouse liver causes hepatic
steatosis. Therefore, I propose that the genomic recruitment of HDAC3 by REV-ERB
directs a circadian rhythm of histone acetylation and gene expression required for normal
hepatic lipid homeostasis.

In Chapter 4, I examined the role of REV-ERB and ROR, two nuclear receptors that
are closely related to REV-ERB. Rev-erb deletion has modest effects on both
circadian rhythms and lipid metabolism. Here I reported that REV-ERB displays
circadian recruitment to the Bmal1 and Npas2 genes, similar to that of REV-ERB.
Depletion of REV-ERB in Rev-erb null liver further decreases HDAC3 recruitment,
derepresses Bmal1 and Npas2 expression, and exacerbates hepatic steatosis. I also
showed that loss of both REV-ERBs abolishes the circadian rhythm in mouse embryonic
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fibroblasts. Our findings established the two REV-ERBs as major regulators of both
clock function and hepatic metabolism.

In the second half of Chapter 4, I reported that ROR binds the Bmal1 and Npas2 genes
with a diurnal rhythm anti-phase to that of REV-ERBs. I showed that REV-ERBs repress
ROR binding at ZT10 and thus drives the diurnal recruitment of ROR, which is
expressed at constant levelsRepression by REV-ERBs is independent of HDAC3,
suggesting that REV-ERBs represses ROR binding through direct competition. I then
identified thousands of competing sites similar to those in Bmal1 and Npas2 genes by
ROR ChIP-seq at ZT10 and ZT22, many of which are in close proximity of clock and
metabolic genes. ROR function in circadian rhythms and hepatic metabolism will be
tested in mouse models of liver-specific deletion of ROR and its paralog ROR. I also
discovered thousands of ROR binding sites with no rhythmic ROR binding, and sites
where ROR bind is in phase with REV-ERBs. How ROR recruitment is regulated at
these non-competing or in-phase sites remains to be elucidated.

5.2 Future Directions
So far I have shown that REV-ERBs direct circadian recruitment of HDAC3 and ROR,
drive rhythmic histone acetylation, and contribute to circadian lipid biosynthesis and lipid
homeostasis in liver. Although evidence suggests that diurnal recruitment of HDAC3 is
regulated by the liver clock, which is the core clock machinery in hepatocytes, I have not
yet demonstrated that HDAC3 recruitment is truly ‘circadian’ and is sustained in the
absence of food intake. In addition, I have focused on how the liver clock regulates
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metabolism, but not yet investigated how the metabolic state and metabolites regulate the
clock through REV-ERBs. In the next step, I will explore how REV-ERB activity is
modulated in liver, particularly by metabolic signals. In Chapter 3, I suggested that REVERBs and HDAC3 may be involved in the development of fatty liver disease in human
caused by circadian misalignment, such as rotating shift work and jet-lag. I would like to
test this hypothesis, and explore how circadian misalignment is associated with increased
risk of metabolic diseases in human. Last but not least, I would like to investigate the
non-redundant functions of REV-ERB and REV-ERB, and further explore HDAC3
function in circadian rhythms.

5.2a Diurnal Recruitment of REV-ERBs and HDAC3—Clock or Food?
As I discussed in Section 1.5, the oscillating liver transcriptome (the once called
‘circadian’ transcriptome) is the result of the oscillating liver clock and the
fasting/feeding cycles. Usually the feeding behavior is aligned with the liver clock, and
they work together to drive rhythmic gene expression and metabolic activities. In the
absence of feeding or food intake, most of the ‘circadian’ liver transcripts can no longer
oscillate. In Chapter 3, I showed that the diurnal recruitment of HDAC3 is sustained in
constant darkness but was reversed when restricted feeding reset the liver clock (Figure
3.6). These findings suggest that HDAC3 recruitment is regulated by the liver clock, the
core clock machinery in hepatocytes. However, in both cases, the liver clock was still
aligned with fasting/feeding cycles, and they could both contribute to the diurnal
recruitment of HDAC3. Is the cyclic REV-ERB and HDAC3 recruitment driven solely by
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the circadian clock or is it also regulated by food intake? To answer this question, I
proposed the following experiments.

To prove that the cyclic REV-ERB and HDAC3 recruitment is driven by the circadian
clock, I will isolate and synchronize mouse primary hepatocytes, and ask if the diurnal
REV-ERB and HDAC3 recruitment sustains in a cell-autonomous manner. But this in
vitro model has one major disadvantage that the isolated hepatocytes cannot maintain the
differentiated state and quickly lose their metabolic capacity. Therefore, we may not be
able to study how REV-ERBs and HDAC3 regulate metabolic genes and metabolic
activities in these cells.

The second experiment was to test whether the diurnal recruitment of REV-ERBs and
HDAC3 is sustained in the absence of food intake in vivo. In this experiment, mice were
fasted from ZT10, and a subset of them was refed 18 hours later at ZT4. We interrogated
REV-ERB and HDAC3 recruitment in mouse liver at ZT22 (12-hour fasting) and at the
next ZT10 (24-hour fasting or 6-hour refeeding after 18-hour fasting) (Figure 5.1A). In
the absence of food (fasting), I observed significant increase in HDAC3 recruitment at
ZT22 in most of the sites we tested, including the Bmal1 promoter, but the diurnal
rhythm of HDAC3 recruitment was partially sustained (Figure 5.1C). This result
indicates that diurnal HDAC recruitment is driven at least partially by the liver clock.
REV-ERB recruitment was also increased significantly at many sites, suggesting that
REV-ERB may contribute to the increase in HDAC3 recruitment (Figure 5.1B).
However, the increase in REV-ERB recruitment was much smaller than that in HDAC3
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recruitment, and this difference may be explained by enhanced HDAC3 recruitment by
REV-ERB upon fasting or by transcription factors other than REV-ERBs. On the
contrary, feeding seems to decrease REV-ERB and HDAC3 recruitment. I observed a
significant decrease in both HDAC3 and REV-ERB binding at ZT10 in the livers of the
refed mice (Figure 5.1B,C). Together, these findings show that rhythmic REV-ERB and
HDAC3 recruitment is regulated by the liver clock and by fasting/feeding. So far, I have
only interrogated a small set of HDAC3 binding sites by ChIP-PCR, and observed
different responses to fasting/feeding among these sites. I plan to expand my study
genome-wide using ChIP-seq. I will also try to understand how REV-ERB and HDAC3
recruitment is regulated by fasting/feeding and test whether changes in HDAC3
recruitment is independent of REV-ERBs.

5.2b Modulation of REV-ERB Activity
So far, I have established the essential role of REV-ERBs in circadian rhythms and
demonstrated a pivotal role of REV-ERBs in regulation of liver metabolism by the
circadian clock. The next step is to understand how REV-ERB activity is modulated by
metabolic signals and others. As I discussed in Section 1.4, the crosstalk between
circadian clocks and metabolism is not unidirectional, and metabolic signals can regulate
clock gene expression and the transcription activity of the clock proteins (Figure 1.5).
The feedback regulation is critical for metabolic homeostasis and fine tuning of the clock
function. The role of REV-ERB in this process remains to be explored.
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First, heme is a REV-ERB ligand Yin et al., 2007). In vitro study showed that REVERB structure and corepressor recruitment can be regulated by the intracellular redox
state and gases such as O2, NO and CO through heme (Pardee et al., 2009; Yin et al.,
2007). This suggests that heme binding to REV-ERB may have important regulatory
functions on circadian rhythms and hepatic metabolism. Does loss of heme binding really
inhibit HDAC3 recruitment by REV-ERB in vivo, and affect the clock and metabolic
gene expression and lipid homeostasis? To answer this question, I plan to inhibit heme
biosynthesis by suppressing the rate-limiting enzyme ALAS1 in mouse liver, and
examine HDAC3 genomic recruitment, clock and metabolic gene expression and liver
triglyceride in response to decrease in heme levels. Secondly, REV-ERB protein
stability and abundance is regulated by phosphorylation and ubiquitination. Is the posttranslational regulation important for circadian REV-ERB expression in mouse liver?
This question can be addressed by ectopic expression of wildtype REV-ERB or mutant
REV-ERB with serine to alanine mutations at varies phosphorylation sites. If my
hypothesis is correct, I should observe oscillation in ectopically expressed wildtype REVERB, and should find little or no mutant REV-ERB in liver. Previously I showed that
REV-ERB binding was significantly down-regulated in the refed mice (Figure 5.1B).
Does REV-ERB protein level decrease? Is it through post-translational modification? I
can address this question by measuring REV-ERB protein levels and GSK3 activation
in these livers.
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5.2c Circadian Disruption and Liver Steatosis
Circadian clocks in our bodies synchronize metabolic events with our daily activity
cycles, and therefore ensure the energy supply and maintain the internal homeostasis. But
this delicate system has been increasingly challenged in modern society. Circadian
rhythm disorders have been observed in a large population due to rotating shift work, jetlag, night eating, sleep disruption and deprivation, and many epidemiological studies
have shown that circadian rhythm disorders lead to a higher risk of metabolic diseases,
including obesity, diabetes and non-alcoholic fatty liver disease. In recognition of these
concerns, the Lazar lab studies the crosstalk of circadian clocks and metabolism through
REV-ERBs, HDAC3s and RORs, and hopes to understand the pathogenic processes of
metabolic disorders caused by circadian rhythm disorders/circadian misalignment.

In Chapter 3, I proposed that misalignment of fasting/feeding and sleep/wake cycles with
endogenous circadian cycles could disrupt rhythmic HDAC3 association with lipid
metabolic genes and contribute to the fatty liver observed in rotating shift workers as well
as people with genetic variants of clock genes (Brunt, 2010; Sookoian et al., 2007).
However, we do not have any evidence that circadian misalignment or genetic mutation
of clock genes affects the circadian binding of HDAC3 and causes liver steatosis. And I
plan to test this hypothesis using mouse models mimicking human circadian rhythm
disorders or genetic mutation of clock genes.

In collaboration with Dr. Loning Fu at Baylor College of Medicine, I first studied a
chronic jet-lag mouse model. Jet lag is a physiological condition that results from rapid
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long-distance transmeridian travel (typically by jet). After landing in a new time zone, the
circadian clock of the passenger is misaligned with the destination time. Both jet lag and
shift work cause circadian misalignment, affect the body clock, and result in similar
symptoms such as fatigue and loss of appetite (Waterhouse, 1999). In our model, mice
were treated with chronic back-and-forth jet-lag since 4 weeks of age. At the beginning
of each week, the light/dark cycle was advanced by 8 hours and stayed for 3 days, and
was switched back and stayed for 4 days (Figure 5.2A). Consistent with the
epidemiological evidence that shift workers may have a higher risk of liver steatosis, we
observed a significant increase in liver triglyderide in the jet-lag mice 3 weeks after the
treatmenet (data not shown, provided by Dr. Loning Fu). In the livers from the jet-lag
mice, HDAC3 still binds genome sites at both ZT10 and ZT22, but the diurnal binding
rhythm was completely abolished (Figure 5.1C). HDAC3 binding in the jet-lag mice at
both ZT10 and ZT22 was lower than that at ZT10 in control mice, but higher than that at
ZT22 in control mice. The intermediate binding of HDAC3 in the jet-lag mice was
consistent with the intermediate expression of both REV-ERBs (Figure 5.2B). Using the
jet-lag mouse model, I showed that chronic circadian misalignment impaired the
circadian clock, abolished diurnal HDAC3 recruitment and caused liver steatosis.

I also tested my hypothesis with Cry1/2 double knock mice (Cry DKO), in which
circadian rhythms are completely abolished (Van der Horst et al., 1999). These mice also
showed a significant increase in liver fat content (data not shown, provided by Dr. Loning
Fu). REV-ERB binding rhythm was abolished, as gene expression no long oscillated in
these mice (Figure 5.3A, B). Since HDAC3 is recruited by REV-ERBs, it too lost the
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binding rhythm (Figure 5.3C). Here I showed that genetic mutation of the clock genes
abolished diurnal HDAC3 recruitment and caused liver steatosis.

My studies on the jet-lag mice and the Cry DKO mice demonstrate that circadian
misalignment or genetic mutation of clock genes affects the circadian binding of HDAC3
and causes liver steatosis. However, I have not yet been able to prove the cause and effect
relationship between loss of rhythmic HDAC3 and REV-ERB binding and fatty liver. To
establish the cause-and-effect relationship, I propose the following studies.

First, I will test whether loss of the liver circadian rhythm causes liver steatosis. Both
chronic jet-lag and Cry1/2 double knockout impair the central clock and the peripheral
clocks, and alter both behaviors and physiology. To focus on the liver clock, I will create
a mouse model in which only the liver clock is “jet-lagged”. A preliminary idea is to
provide food only for 4 hours a day, and at the beginning of each week advance the
feeding time for 8 hours and switch back 3 days later. The back-and-forth shift in timely
restricted feeding should impair the rhythmic expression of clock genes in major
metabolic organs, particularly liver, yet have no minimum effects on the central clock. I
will then test whether the feeding regimen abolishes HDAC3 recruitment rhythm, affects
circadian and metabolic gene expression, and causes increase in liver triglyceride content.

The key experiment to establish the cause-and-effect relationship is to ectopically express
REV-ERB and/or REV-ERB in liver to a stable intermediate level observed in the jetlag mice. To eliminate the effects of endogenous REV-ERBs, I will perform this
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experiment in mice with genetic deletion of both Rev-erb/ in liver. These mice will be
housed under regular light/dark cycles and allowed free access to food. If liver
triglyceride is increased in mice with a stable intermediate level of REV-ERB, we may
conclude that circadian misalignment abolishes rhythmic HDAC3 and REV-ERB binding,
and thus leads to fatty liver. And this finding will strongly support the role of HDAC3
and REV-ERBs in the development of non-alcoholic fatty liver disease in human with
circadian rhythm disorders.

In summary, my studies using the chronic jet-lag mouse model and the Cry DKO model
agree with the hypothesis that the impaired HDAC3 binding rhythm is involved in the
pathogenesis of fatty liver caused by circadian disruption. These mouse models mimic
circadian misalignment in human, and therefore may provide useful insights into the
onset of human fatty liver disease.

5.2d Non-redundant Roles of REV-ERB and REV-ERB
In Chapter 4, I showed that REV-ERB and REV-ERB have almost identical roles in
transcriptional regulation, and overlapping functions in circadian rhythms and hepatic
lipid metabolism. As a result, I have always been asked if these two always share the
same role. The answer may be ‘No’. First, REV-ERB and REV-ERB have slightly
different expression rhythms. Although they mostly bind the same genomic regions and
are likely to share the same gene targets in liver, they may repress these targets at slightly
different times of the day. Secondly, REV-ERB and REV-ERB may be expressed at
different abundance in liver. Therefore, one may be more important than the other in the
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liver clock and liver metabolism. Last, REV-ERB and REV-ERB bind to the Rev-erb
promoter, but not the Rev-erb promoter, and this difference hints that REV-ERB and
REV-ERB are not equal in the core clock machinery. Indeed, genetic deletion of Reverb has a more significant effect on circadian rhythms compared with genetic deletion
of Rev-erb(Cho et al., 2012). To compare the roles of REV-ERB and REV-ERB in
the liver, I plan to use the conditional null models for both genes, and carefully examine
gene expression changes in response to liver-specific deletion of REV-ERB and/or
REV-ERB. In Chapter 3 and 4, I tested the function of REV-ERB and REV-ERB on
circadian rhythms and hepatic metabolism using germline deletion of Rev-erb or an
adenovirus that encodes shRNA targeting Rev-erb. But I cannot accurately compare the
roles of REV-ERB and REV-ERB by using two different methods, not to mention that
each method has major drawbacks. Germline deletion leads to complete loss of Rev-erb
throughout the body, and adenovirus encoding shRNA has off-target effects and induces
immune response and liver toxicity. Aware of these drawbacks, I also hope to validate all
my previous findings using the conditional null models for Rev-erbs.

Although REV-ERB and REV-ERB may share the same genomic binding and gene
targets, they could respond differently to cell signaling and have different physiological
roles. For instance, REV-ERB is subject to post-translational regulation by GSK3 and
E3 ubiquitin ligase ARF-BP/PAM. GSK3 phosphorylates serine 55 and 59 in the Nterminal domain of REV-ERB, and protects REV-ERB from ubiquitination and
degradation. The GSK3 phosphorylation motif is not conserved in REV-ERB. This
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raises two possibilities. First, loss of REV-ERB affects a subset of metabolic genes, and
REV-ERB protects the rest metabolic pathways and the circadian clock. This could be
addressed by carefully comparing the Rev-erb conditional null models discussed earlier.
Second, REV-ERB, but not REV-ERB, receives environmental signals and adjusts the
liver clock. This is supported by a previous finding in the lab that serum shock induces
REV-ERB degradation through ARF-BP/PAM.

In summary, I would like to address the non-redundant functions of REV-ERB and
REV-ERB in liver by comparing gene expression in response to loss of either REVERB, and by studying how REV-ERBs are differentially regulated in response to
systematic signals, such as insulin, glucocorticoid and serum shock. I also plan to test if
the redundancy of REV-ERB and REV-ERB observed in liver also exists in other
major metabolic organs, such as adipose tissues and muscle.

5.2e HDAC3 in Circadian Rhythms and Others
HDAC inhibitors are widely used in clinical trials and treatments in psychiatry,
neurology, cancer and inflammatory diseases, and many of them inhibit HDAC3 activity.
Therefore it is important to have a thorough understanding of different physiological
functions of HDAC3. This knowledge will help predict and reduce the side effects of
HDAC inhibitors, and will help uncover new applications for them.
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In Chapter 3 and Chapter 4, I reported that REV-ERBs recruit HDAC3 to repress clock
genes such as Bmal1 and Npas2. Do REV-ERBs recruit HDAC3 to repress clock genes
in the central clock and other peripheral clocks? Is HDAC3 required for normal circadian
rhythms? To answer the first question, I will examine HDAC3 recruitment at the Bmal1
and Npas2 genes in the SCN and other peripheral tissues, such as fat and muscle. To
determine if HDAC3 is required for normal circadian rhythms, I will cross the HDAC3fl/fl
mice to Rosa26-Cre-ER mice (these mice display tamoxifen-inducible Cre activity in all
tissue types), and induce HDAC3 deletion in adult mice. We can then assess the circadian
rhythms in these mice by measuring clock gene expression in the SCN and many
peripheral tissues, such as liver, muscle, and fat, and by measuring food intake and
locomoter activity in regular light dark cycles and in constant darkness. An alternative is
to delete HDAC3 in mouse embryonic fibroblasts and measure the oscillation of clock
genes after serum shock.

In Chapter 3, I reported a surprising overlapping between REV-ERB and HDAC3
genomic binding, and showed that recruitment of HDAC3 at many sites are REV-ERB
dependent. But it is unlikely that HDAC3 is completely ‘enslaved’ by REV-ERBs in
other tissues. Indeed, HDAC3 may not even be recruited by nuclear receptors, as shown
in macrophages (Mullican et al., 2011). In the future, I hope to explore HDAC3 functions
in other tissues and understand how HDAC3 is recruited in these tissues. I will focus on
metabolic organs, such as muscle, heart and adipose tissues, and begin with HDAC3
ChIP-seq. ChIP-seq may reveal HDAC3 targets that account for the metabolic disorders
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induced by HDAC3 deletion in these tissues (Sun et al., 2011), and motif analysis of
HDAC3 cistromes helps identify transcription factors that mediate HDAC3 recruitment.
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Figure 5.1 REV-ERB and HDAC3 Recruitment in Response to Food Intake.
A. Wild type were fasted and refed as indicated in regular light/dark cycles. The gray
area indicates the period without food. Liver tissues were collected at ZT22 and ZT10/34
as indicated by the arrow.
B. C. REV-ERB (B) and HDAC3 (C) recruitment in livers collected in A were
interrogated by ChIP-PCR. Values are mean ± s.e.m (n=4-5).
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Figure 5.2 Loss of HDAC3 Binding Rhythm in Jet-lag Mice.
A. The chronic jet-lag treatment. Each week, the light/dark onset time was advanced by 8
hours; 3 days later, it was switched back until next week.
B. Bmal1, Rev-erb and Rev-erb expression was measured in livers harvested at ZT10
and ZT22 from 14 week old jet-lag mice or mice housed under regulator light/dark cycles
(WT). Values are mean ± s.e.m (n=3).
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C. HDAC3 (C) recruitment in livers harvested at ZT10 and ZT22 from 14 week old jetlag mice mice housed under regulator light/dark cycles (WT). Values are mean ± s.e.m
(n=3).
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Figure 5.3 Loss of HDAC3 Binding Rhythm in Cry DKO Mice.
A. Bmal1, Rev-erb and Rev-erb expression was measured in livers harvested at ZT10
and ZT22 from 14 week old Cry DKO mice. Values are mean ± s.e.m (n=3).
B. C. Rev-erb (B) and HDAC3 (C) recruitment in livers harvested at ZT10 and ZT22
from 14 week old Cry DKO mice. Values are mean ± s.e.m (n=3).
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